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CELLULAR DIFFERENTIATION IN BONE 
Discussion Leader: 
DR. JOHN J .  PRITCHARD 
PRITCHARD: Ladies and gentlemen, we shall be talking this morning 
about “Cellular Differentiation in Bone.” The first difficulty is the 
lack of precision in this word “differentiation.” There are several 
meanings, and quite possibly we shall be thinking about differentiation 
in different ways at different times. You may have other meanings 
that I have not thought of, but perhaps for the moment I may be allowed 
to tell you how I think the word “differentiation” can be parsed and 
analyzed. 
First, the word “differentiation” can apply, and often is applied, 
to a population of cells. Secondly, the word “differentiation” can 
apply to some individual cell within a population. It depends on 
whether our attention is focused on the whole population or on one 
particular element in that population. 
Then again, we can focus on static or instantaneous aspects of 
differentiation, the idea of differentiation being, like beauty, in the 
eye of the beholder. The beholder sees a picture; he sees it made 
up of differing elements and tries to differentiate, delineate, and clarify 
the elements into species, to which he gives names. This is purely 
a static analysis; time does not enter into it. You could all die sud- 
denly, but you could still be differentiated by your appearances and 
classified into groups, and that is normally what the histologist does. 
He  may think he is doing something more dynamic, but really he is 
analyzing a dead, fixed picture. 
The “static” man is simply concerned with differences within a 
population at a given point in time. The dynamic aspect of differentia- 
tion is concerned with change, but even here there is more than one 
meaning behind the idea of change. There is the idea of the homogene- 
ous becoming heterogeneous, with differences arising and increasing 
as in the development of an embryo. There is also the idea of the 
transformation of one mode into another mode without it necessarily 
being part of an ontologic process. 
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In these transformations there are those we consider irreversible, 
sometimes called true differentiation, and those changes which we 
consider to be reversible, often referred to as “modulation.” 
Under the heading of “differentiation,” therefore, we have population 
studies, individual cell studies, static studies, dynamic studies. Cellu- 
lar differentiation in bone thus implies at least four kinds of activity. 
FREMONT-SMITH: “Irreversible” means not yet known to be 
reversible. 
PRITCHARD: That is true. It also means that the change is carried 
on to the next generation of cells. 
FREMONT-SMITH: The inheritance of an acquired characteristic. 
PRITCHARD: Yes; from one cell to another, not from one organism 
to another. Some of you may want to add to this analysis of what we 
mean by “differentiation.” In the meantime, I would like to add one 
or two more guidelines to the discussion. Suppose we begin with 
the concept of a bone-cell population. These populations are not the 
same everywhere. There is a great variation in the local populations 
in different parts of a bone, in different bones, at different ages, in dif- 
ferent species, in different functional states. So, we have variations 
in populations. 
There are also variations within a population. This takes into 
account the heterogeneity within a given population. We are looking 
eventually for differences between cells. We have to be careful 
about the criteria we use for differentiating cells, and we have to 
spend a little time, I think, on nomenclature. What are we going to 
call those cells once we differentiate them out of the population? 
These questions belong to the static level of histologic study. Dy- 
namic studies may be summed up as activities of the population of bone 
cells. This covers a multitude of topics, and we obviously cannot 
discuss them all. However, I want to give a fairly complete frame of 
reference and then select some of the more important issues; you can 
introduce other important ones. 
Under activities of a population, we must not forget the movements 
of cells, which are sometimes ignored. There are respiratory and 
secretory activities. There is mitosis, and death of cells. There 
is the recruitment of cells to a population, and there is the emigration 
of cells from a population. 
How 
did they get that way? 
Finally there is differentiation. 
FREMONT-SMITH: You start with a population of bone cells. 
PRITCHARD: You mean, do we get cells from outside? 
FREMONT-SMITH: here is an ontogeny of these cells- 
PRITCHARD: An ontogeny which consists of mitosis followed by 
migration, differentiation, modulation, transformation, functional 
activity; in other words, the population has a lively history which can 
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be traced back to embryonic beginnings at an ossification center, 
and perhaps even earlier. Moreover, these activities are under 
control. 
In principle, I think there are three kinds of control that can be 
exerted over the activities of the population. First, there is control 
from outside the population, directly issuing from sources external 
or extrinsic to the population. One thinks of hormones, mechanical 
factors, toxic substances - anything that can get at a population fiun 
outside. 
FREMONT-SMITH: Do you consider induction as part of that? 
PRITCHARD: Induction is sometimes controlled from outside, 
sometimes from inside. 
FREM0NT-SMn-H: You are starting as if we already had a population 
of bone cells. 
PRITCHARD: We will go back and prove that there is a population 
later on. But assume that there is a large population of cells and that 
these cells are active in some of the ways I have mentioned; then we 
could have influences on the activity of a population arising from 
outside the population. We could also have mutual influences of the 
cells upon one another within the population. 
We also have influences or determinants which come from the cell 
itself, the DNA in one cell perhaps being in a different state from the 
DNA in another cell. Therefore, there are controls extrinsic to the 
population and controls intrinsic to the cell. 
Then, there are some final considerations: How do these controls 
work? Do controls affect the population by affecting the mitotic 
rate of some particular stem cell? Do they affect the secretory activity 
of some already modulated cell? Do they influence membrane func- 
tions in some of the cells? Or do these controls work at the DNA- 
RNA synthesis level? Just what kinds of controls and regulations 
are present, and how do they work? 
These are my four major headings: the static attributes of the popula- 
tion, the activities of the population, the controls, and the mechanisms 
of control. Some key problems center around the criteria for iden- 
tifying cell types and giving them names. The most important problem 
is tracing individual cell lineages through serial mitoses and isolation. 
The most pressing problems, however, concern the controlling 
mechanisms - and we tend to think immediately of induction and 
hormone action. I would like to add to these the action of the vascular 
system on the population; there are also mechanical and nutritional, 
even nervous, influences to be considered. In the last analysis, all 
these influences may well have a final common path through the cell 
nucleus; at present we are at the stage of cataloging the factors and 
their visible and chemical effects on the population. 
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Returning to the concept of bone-cell populations, I would like to 
emphasize the continuity of the populations. We do not very often 
see a bone as a whole or think about its cell population in toto. In 
histologic preparations of small bones from young animals, one does 
get the idea of a continuum of cells within subpopu!ations in the perios- 
teum, the bone marrow, the cortex, the metaphyses, and the epiphyses. 
When we discuss the characteristics of these subpopulations we would 
do well to remember that they are part of a continuum which starts 
from the periosteum, goes through the bone cortex, and on up and down 
the marrow into the metaphyses. 
A young 
bone has a fairly open cortex-that is, the periosteum-with part of its 
bone-cell population, the periosteum, in place. This is continuous 
with the bone-cell population, working through the interstices of the 
cortex. Then there is the population of the bone marrow through and 
including the special population of the endosteum at the surface of 
the bone marrow. Then we have the population going up into the 
resorption spaces, and then we have an independent population of the 
bone cells in the epiphysis. While this is an independent population, 
all the rest are really forming a continuum; there is no very great 
difference, in many cases, between the periosteum population in the 
cortex, the population within the marrow, and the population in the 
metaphysis. 1 think we were trying to differentiate between me- 
taphyseal bone, cortical bone, and cancellous bone as if each were an 
entirely different species of bone. I think, in reality, if we trace their 
development we could see how the appearance of the bone gradually 
hardens and crystallizes out from a fairly basic unified pattern. 
In any section of bony tissue taken from a young animal, one is liable 
to be confronted with a bewildering variety of cell types. There are 
plump osteoblasts and multinucleated osteoclasts on bone surfaces, and 
osteocytes of different kinds imprisoned within the bone matrix. There 
are “fibroblasts” in the outer layers of the periosteum and in the con- 
nective tissue around the larger blood vessels of the bone marrow. 
There are endothelial cells of blood vessels, leukocytes and erythrocytes 
in all stages of maturation, and fat cells. In the chicken bones I have 
been studying there are masses of nucleated erythrocytes in the blood 
vessels, which adds to the confusion. In addition to all this, there are 
certain nondescript, unspecialized-looking cells to be seen almost 
everywhere; these cells do not fall into any of these categories. They 
are present in the depths of the periosteum, around the fine vascular 
channels of cortical bone, in the spaces of cancellous bone, lining the 
medullary surface of the cortex, and scattered throughout the bone 
marrow. They have been given many names, and they have long been 
regarded as a reserve of uncommitted cells from which new osteoblasts I 
Let us consider bone from the point of view of population. 
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are recruited during growth and repair. Their status has been made 
much clearer since the introduction of tritiated thymidine as a nuclear 
label. It is now realized that these reserve cells can multiply and 
differentiate into a variety of specialized cell types including osteo- 
blasts, osteoclasts, and chondroblasts. 
Plump osteoblasts and 
osteoclasts are found only occasionally, most bone surfaces are covered 
with exceedingly flat cells, and the reserve cells mentioned are very 
difficult to identify. Yet if mature bone is stimulated by injury, for 
example, its cell population rapidly takes on the appearance it had in 
its youth. The flat cells rapidly fatten into osteoblasts, and near them 
reserve cells become conspicuous. Osteoclasts also soon make their 
appearance. It would seem that the cell population can go into 
hibernation, and then be awakened. 
If we grant that bone contains a ubiquitous population of multipoten- 
tial reserve cells, then the consequences of stimulating them to divide 
and to differentiate will be far reaching. Indeed, the obvious method 
of regulating bone activity would be exerting control over the multiplica- 
tion and differentiation of these reserve cells. I should expect that 
much of our discussion will center around these cells and the factors 
which regulate their activity. But first perhaps we should agree on a 
generic name for them. 
In mature bone the case is quite different. 
URIST: Would you call them mesenchymal cells? 
PRITCHARD: I do not think that the name is as important as knowing 
that they are there. I think it is more important to delineate them by 
definite properties - what they can do, what they cannot do, how they 
stain, and so forth. 
URIST: If the animal had one injection of tritiated thymidine, where 
would the label be located? 
PRITCHARD: I suspect it would go into some members of the reserve- 
cell population in the first few hours. 
URIST: The 3H-thymidine would not go into the endothelial cells 
in any great amount. 
PRITCHARD: No; because they are not about to divide. 
URIST: The next layer, the nondividing cells, would not utilize a 
large amount of 3H-thymidine. Only the population of cells, the 
progenitors, preparing to divide rapidly and in large numbers would 
be expected to be labeled with 3H-thymidine. 
PRITCHARD: But you would not know it was about to divide unless 
it took up thymidine and told you so. Otherwise, you probably would 
not notice it. 
BELANCER: I think we know what our chances are for seeing the 
thymidine go to one area or another by the amount of mitotic figures 
which we can observe in a normal preparation. 
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PRITCHARD: Where does it go to? 
BELANGER: Yes. 
You mean in relation to the 
bone as a whole? 
I am trying to get an answer for Dr. Urist. The 
use of thymidine is a very sophisticated approach to this kind of thing. 
Before thymidine was available it was possible to predict where it 
would go proportionately by the amount of mitotic figures thatwe could 
observe, particularly after colchicine, a very simple technique that 
anyone can do. 
PRITCHARD: This comes under the question of the criteria we are 
going to use to differentiate different types or modulations of cells 
in a population. Could we keep to static considerations for a while, 
and deal with dynamic aspects later? 
When you administer thymidine and label a cell, that presumably 
is a static study. You do not actually see the cell dividing; you merely 
have evidence that it is about to divide or that it has divided. 
On this basis, Dr. Belanger, what types of cell would you recognize 
in a bone population? 
BELANGER: Do you mean in relation to thymidine? 
PRITCHARD: Yes; in relation to thymidine. You can divide the 
population in many ways: in relation to phosphatase, in relation to 
glycogen, in relation to size and shape of cells. However, in relation 
to thymidine, what cells would you recognize? 
B~LANGER: I think we should ask Dr. Young, who has firsthand 
information on this sort of thing. I think we agree on some aspects 
about that. Some people do not agree, I believe, on the actual names 
which are given to these cells, but we all agree that they are what you 
call reserve material, what Cronkite et al. (ref. 108) call primitive 
cells, what Young calls osteoprogenitors (ref. 109), and what embryolo- 
gists like to call mesenchymal cells; they are all the same. These are 
the cells in which you would expect most of the thymidine to be 
located- in all those areas, including the endothelial wall where there 
is a very rapid renewal of the cell population from other endothelial 
cells. 
PRITCHARD: Do they remain endothelial? 
B~LANGER: I do not know, but certainly the endothelium renews 
itself in great part, except wherever new vessels appear from the 
mesenchyme from other cells in the wall. 
PRITCHARD: Dr. Young, would you talk about the distribution 
of tritiated thymidine in a bone-cell population, without perhaps 
at this stage going into family histories and so on, but sticking to what 
you actually observe when you use thymidine? 
YOUNG: My experience has been that one can distinguish at least 
four functional states of the bone cell. These states would include 
the three classic cell types: osteoblasts, osteoclasts, and osteocytes. ~ 
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In addition, there is a pale-staining, rather spindle-shaped, cell which 
so far we have been hesitant to name. I call this cell the osteoprogeni- 
tor. It utilizes tritiated thymidine in synthesizing DNA prior to cell 
division and serves as a source of new bone cells. 
The classic cell types are, generally speaking, incapable of reproduc- 
ing themselves. However, the bone cell is capable of assuming a 
specialization in which it can divide, and it is in this state that it takes 
up thymidine. 
While we are on the static aspect, I would like to show some figures 
which indicate that although (I will develop this later if time permits) 
the three classic cell types are all ultimately derived from cells produced 
through mitosis of the osteoprogenitor, they are nevertheless func- 
tionally different. 
PRITCHARD: Is that static? I would have thought that was a dynamic 
problem. 
YOUNG: I have proof for this statement, but have only mentioned 
it now as a background for the figures I will show. 
If we examine, by autoradiography, the specialized cells in bone 
l12 hour after injecting tritiated glycine, we immediately see that these 
cells are functionally different (ref. 1 lo). Figure 60(a) is an osteoclast 
which has utilized, relatively speaking, practically none of the injected 
glycine; whereas the osteoblasts in the very immediate vicinity, having 
access to the same tissue fluid, have concentrated the glycine in their 
cytoplasm in the act of protein synthesis. Glycine shows the greatest 
contrast between these two cell types because it is the most common 
amino acid in collagen, which is, of course, what these osteoblasts 
are largely synthesizing. 
PECK: What is the evidence that glycine is in protein? There are 
many functions for amino acids in a cell besides incorporation in 
protein. 
YOUNG: It can be shown biochemically that if one supplied these 
cells with tritiated glycine or 14C-glycine, the radioactivity can shortly 
thereafter be recovered in collagen; but autoradiographers using this 
sort of technique have to accept the fact that practically all low molecu- 
lar weight compounds are washed out in preparation of the sections. 
The result is that we are looking, in a sense, at a nucleoprotein carbo- 
hydrate residue of what used to be there. 
Within 4 hours, most of this labeled protein is released from the cells 
(fig. 60(b)). The osteoblasts are now essentially devoid of radio- 
activity, and they have laid it down on the surface of the matrix. 
Osteocytes, which are, after all, just trapped osteoblasts, also use 
tritiated glycine (fig. 60(c));  at least the new ones do, such as we saw 
yesterday in the elegant micrographs presented by Dr. Robinson. 
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FIGURE 60. Photomicrographs of sections from tibial metaphysis of I -week-old rats, 
sacrificed 30 minutes after injection of 3H-glycine. Autoradiograph, PAS-hematoxylin 
stain. 900 X. 
Note 
that the osteoclast (below, center) has incorporated very little of the radioactive protein 
precursor. 
(b)  The osteoblasts have deposited radioactive protein on the surfaces of the adjacent 
bone trabeculae. 
(c)  Newly formed osteocytes (above) are actively synthesizing protein. Older osteo- 
cytes (below) are relatively inactive in this regard. 
(d) Newly formed osteocytes have deposited the radioactive protein on the surface of 
their lacunar walls. 
(a )  Osteoblasts have concentrated large amounts of the labeled amino acid. 
These cells are also synthesizing bone matrix. The older osteocytes, 
which are smaller and in smaller lacunae, use little or no glycine. 
Within 4 hours, the newly formed osteocytes lay down the radioactive 
matrix on the surface of their lacunae, which they are remodeling into 
smaller, more almond-shaped cavities (fig. 60(6)). 
BELANGER: Is this a rat, Dr. Young, or a mouse? 
YOUNG: This is rat bone. I have been talking here about glycine. 
We have also looked at many additional amino acids (ref. 1 1 1 ) .  From 
these figures, one might draw the conclusion that the osteoclasts and 
osteoblasts were doing the same thing, but at different rates. However, 
if we try a large series of precursors, we will find that the labeling 
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relationships between osteoclasts and osteoblasts differ. They are 
handling each precursor according to their own preference. 
With some precursors, such as proline, there is still a high ratio 
of labeling in osteoblasts as compared with osteoclasts. In others, 
such as alanine (fig. 61(a)), the distinction is perhaps not quite so 
great. 
FIGURE 6 1. Photomicrographs of sections of tibial metaphysis of rats after injection of 
tritiated compounds. Autoradiograph, PAS-hematoxylin stain. 900 X. 
Difference 
in labeling between osteoclast (left) and the osteoblasts is not as marked as with glycine 
and proline. 
Difference 
in labeling between osteoclast (left) and osteoblasts is even less. 
Large, heavily 
labeled osteoclast (c)  on surface of unlabeled bone matrix (b) appears to be engulfing an 
unlabeled cell (below, center). Glutaraldehyde fixation. 
(a) One-week-old rat, sacrificed 30 minutes after injection of 3H-alanine. 
(b) One-week-old rat, sacrificed 30 minutes after injection of 3H-histidine. 
(c) Eight-week-old rat, sacrificed 1 hour after injection of 3H-taurine. 
With histidine (fig. 61 (b)), the labeling in osteoblasts and osteoclasts 
is fairly comparable, although on a per nucleus basis it is still higher 
in osteoblasts. 
In some cases, such as this unusual precursor (fig. 61(c)), we find 
that the osteoclasts are very strongly radioactive, and the osteoblasts 
are relatively less heavily labeled. 
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This label is taurine; it is not an amino acid. It is believed to be a 
waste product, a breakdown product of the sulfur-containing amino 
acids. It is actually the first precursor that I have found which appears 
to be preferentially concentrated in osteoclasts. 
I think that although we are able to distinguish these cells morpho- 
logically, these differences in appearance reflect underlying differences 
in the metabolic organization of the different functional states of the 
bone cell. 
NICHOLS: Dr. Young, is it not true that the osteoblasts may be active 
in this sense in some areas of the bone, and in other ways not so active? 
Can you really use amino acid uptake as a reliable criterion for identi- 
fication? 
YOUNG: I have never observed a cell which was a full-blown osteo- 
blast with well-developed endoplasmic reticulum, Golgi complex, and 
so on, that did not avidly concentrate protein precursors. One expects 
to find osteoblasts that are beginning to respecialize, perhaps as osteo- 
progenitors, or osteoprogenitors that are beginning to specialize as 
osteoblasts. These will not show the full response, the highest rate 
of bone formation. However, generally speaking, any cell which is 
histologically recognized as an osteoblast will, upon autoradiographic 
analysis, prove to be synthesizing bone matrix. 
HOWELL: How old are the animals that you studied? 
YOUNG: These are young animals. In old animals in a region of 
quiescence in bone, the osteoblasts are not fully developed; they 
tend to be flattened. They will show some uptake because they are 
indeed alive, their enzymes are turning over and so on; but here again 
the morphologic picture, for those who are not using autoradiography, 
can serve as a fairly good guide to the activity of the cell. 
BELANGER: Is there a parallel between the cells that pick up thymi- 
dine and those that pick up the amino acids? 
YOUNG: All cells that are alive are going to use some of the amino 
acids. Those that have reorganized their metabolic machinery in 
order to synthesize collagen are nondividing. Dr. Holtzer would 
agree with me, I think, that the cells which are highly specialized for 
some specific function are generally not dividing cells. 
NICHOLS: A couple of years ago Dr. Owen made some autoradio- 
graphs of bits of pig bone which I had incubated with tritiated proline. 
We observed quite active uptake in the osteoblasts in some areas 
and in other areas practically none. We also observed labeling of 
osteocytes similar to that with glycine. Dr. Owen, is my memory 
correct? 
However, I would like to make one point. In very 
young animals (about 1 week old), such as Dr. Young and I have 
used, all the osteoblasts are actively synthesizing collagen. In older 
OWEN: Yes. 
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animals only selected regions of osteoblasts synthesize collagen; 
other regions are quiescent. Dr. Nichols’ material consisted of bone 
chips from older animals. 
NICHOLS: All right, but what I am trying to get at is that an osteo- 
blast can be considered an osteoblast, at least by a biochemist, and 
still not be making much collagen at the time. I think that this is an 
important point because I have the notion that differentiation can occur 
without the cell necessarily having to perform the function for which it 
is now differentiated. In other words, a runner does not necessarily 
have to be running all the time to be recognized as a runner. He  can 
occasionally stop. 
RAISZ: Were those precursors given in vivo or in vitro? 
NICHOLS: In vitro. 
RAISZ: I would object to the interpretation on the ground that the 
function of some of the cells may have altered since they were removed 
from the animal. 
TALMAGE: I am sure there are differences in the rate in which 
various osteoblasts take up protein and synthesize collagen. For 
example, it has been demonstrated in the rat that osteoblasts in the 
metaphyseal region of the femur turn over radioproline at a much 
faster rate than do osteoblasts in the shaft of the same bone. 
NICHOLS: We can demonstrate very clearly that proline went through 
the osteoblasts in the metaphysis at a much faster rate than it did 
through the osteoblasts in the cortex of a rat bone. After one-half 
hour a fair amount of metaphysis had gone into collagen whereas in 
the diaphysis, 96 percent was still left in the cell. We followed through 
to 4 hours and were able to draw a curve on the rate in which osteo- 
blasts in different parts of the bone were synthesizing proteins. 
PRITCHARD: As a matter of fact, we are trying to get to the criteria 
for distinguishing species of cell in the population. These different 
cell types are going to vary in their activity from time to time. Using 
the criterion of labeled amino acid uptake, there appear to be dif- 
ferences between the kinds of cell which morphologically we term 
osteoblasts, osteoclasts, and marrow cells. 
Metabolic criteria are important, but we must not forget that there 
are other ways of distinguishing the elements of this population. As 
I have indicated, shape, size, and gross internal structure were all 
that the classic morphologist had to go on for a number of years. 
When he saw a cell with long, thin processes, with a large nucleus at 
one end, an enormous negative Golgi area in the middle, a basophilic 
cytoplasm full of mitochondria, and when that cell was sitting on a 
bone surface, he called it an active osteoblast. 
When he saw a much larger cell with many nuclei, a large number 
of mitochondria, and residing in an excavation on the bone surface, 
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he called it an osteoclast. He forgot to talk about or only mentioned 
in passing, as a rule, the other cells present, because they did not 
have these very distinctive morphologic features. 
Then there are staining reactions. The cytoplasm may be either 
eosinophilic or basophilic, or a mixture of the two. 
Another criterion, of course, is enzyme activity. There seems to 
be no limit to histochemical criteria. One cell type may have very 
high alkaline-phosphatase activity, whereas another cell type may have 
a very high acid-phosphatase activity. Succinic dehydrogenase 
activity may be high in one type of cell, and in another type there may 
be low isocitric dehydrogenase activity and so on. 
We have not yet mentioned tritiated thymidine, which is mainly used 
to determine family relationships within a dividing, differentiating 
population. But thymidine is also a static criterion in that we can 
distinguish certain cells that take up thymidine immediately from those 
that do not. I am sure there are many other physical and chemical 
criteria waiting to be tried. We certainly have enough criteria. Are 
we in a position to classify the cell types and agree on names for them? 
What shall we call the cell that lies on a bone surface looking like an 
osteoblast that has been flattened? I t  still has a nucleus at one end, 
it still has the big negative Golgi image, and it still is basophilic; but it 
is as flat as a pancake. 
Nevertheless it is ubiquitous and, moreover, I have seen many 
transitions between this type of cell and the plump classic osteoblast. 
I would like to suggest that the flat cell is a resting osteoblast, and the 
plump cell is an active osteoblast. I t  seems that when an osteoblast 
has stopped being very active, it may not necessarily go back to a 
progenitor stage but may just go back to a resting stage, while retaining 
its potential as a working cell. 
BELANGER: It is a very important point, Dr. Pritchard, if I may say 
so, that not all osteoblasts become osteocytes. Some become resting 
osteoblasts. I do not know now whether I agree with Dr. Young that 
they may go back to being mesenchymal cells or young cells, but some 
active osteoblasts, a fairly large number- depending on where we are 
looking in the bone and depending on the actual growth potential of the 
site-will go into the resting state; we can follow the thymidine through 
time into these or into osteocytes. In other words, the number of 
osteocytes does not account for the number of osteoblasts which 
showed the thymidine previous to that stage. 
This cell type is rarely mentioned. 
SAXEN: Could you define the resting stage? 
BELANGER: This is the particular stage that Dr. Pritchard discussed. 
PRITCHARD: Most bone surfaces in the adult are covered with a 
pavement of flat cells. These cells have certain osteoblastic features. 
Their long processes go into the bone, the nucleus is at one end, and 
there is a large ce 
of cytoplasm or t 
but there is no e 
resorption. These are the cells that we need to name. I call them 
resting osteoblasts. 
NICHOLS: Does anybody have an electron micrograph of one? 
PRITCHARD: r. Robinson showed them. 
OWEN: Our studies of the kinetics of cell differentiation on the 
periosteal surfaces of young rabbit femur may be of interest at this 
point. We have measured the rate at which preosteoblasts -perhaps 
I should not use that term- 
FREMONT-SMITH: Why not? 
OWEN: I mean the rate at which the precursor cells of the osteo- 
blasts differentiate to become osteoblasts, and then the rate at which 
the osteoblasts go on to become either osteocytes or osteoblasts living 
in haversian canals. We found no evidence of any cell death in this 
system. All osteoblasts originally on the surface eventually became 
either osteoblasts in haversian canals or osteocytes within the matrix, 
about 60 percent and 40 percent, respectively, in the two categories 
(ref. 112). 
FREMONT-SMITH: No resting cells? 
OWEN: The osteoblasts in haversian canals, especially those deep 
within bone, are resting osteoblasts. 
PRITCHARD: r. Owen, would you tell us what your criteria were? 
I have given my criteria for the population of resting osteoblasts. 
What would your criteria be? 
OWEN: In our particular study it was not necessary to define resting 
osteoblasts. However, I am more or less in agreement with your 
definition. In our material, haversian canals that are deep within the 
bone have osteoblasts on their surface which I would describe as 
resting. The cells are flattened against the surfaces of the lumen and 
do not show detectable labeling with tritiated glycine. 
PRITCHARD: In other words, location, rather than any specific 
morphologic feature. 
OWEN: Yes; in this particular study the main criterion was location. 
MCLEAN: What about the alkaline phosphatase? 
OWEN: I would like, at some time, to put in a plea for the term 
“preosteoblast,” because I think there may be several stages included 
in the osteoprogenitor stage of the cell. Balogh and Hajek (ref. 113) 
found different histochemical staining reactions in osteoprogenitor 
cells in different situations. In their studies, what they describe as 
the osteoprogenitor cells of the periosteum show a moderate staining 
activity for isocitric dehydrogenase and glucose-6-phosphate dehy- 
drogenase, whereas these enzymes were not demonstrable in the 
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osteoprogenitor cells of fracture callus. They also describe, in frac- 
ture callus studies, mononucleated cells showing succinic dehydro- 
genase reactions; the enzyme specific for osteoclasts in bone. They 
suggest that these mononuclear cells may be precursors of the multi- 
nucleated osteoclasts - might I suggest the term “preosteoclast.” 
Walker (ref. 114) also described mononuclear or binuclear cells with 
strong succinic dehydrogenase activity in bones treated with para- 
thyroid hormone. If the proliferating precursor stage of bone cells- 
the osteoprogenitor stage (ref. 109) - does consist of several stages, 
this would fit well with what has been found in other tissues; for ex- 
ample, the well-known multiple stages of proliferating precursor in the 
blood series. More recently Combs et al. (ref. 115) reported several 
stages which were histochemically and autoradiographically distin- 
guishable of proliferative precursors in mast cells. 
URIST: Does Dr. Owen propose that a gradation of changes in cell 
metabolic reactions could occur in the course of mitotic division? 
PRITCHARD: She did not really say that. 
URIST: I will restate the question. There is a series of mitotic divi- 
sions, and there is an arrangement of cells in layers. The layers con- 
sist of perivascular Gonnective tissue cells, mesenchymal cells, and 
connective tissue cells closest to the bone, which are preosteoblasts. 
In  my mind this raises the question of whether another criterion, the one 
Dr. Nichols mentioned, that of ultrastructure, can rescue us from the 
dilemma of morphology under the light microscope. 
Can Dr. Robinson and his associates, who are familiar with these 
cells in the electron microscope, distinguish between a perivascular 
connective tissue cell in a muscle and a perivascular connective tissue 
cell in a bone? I think that is what I am searching for in order to iden- 
tify a cell by its potential for function. 
PRITCHARD: We are trying to arrive at some objective, incontro- 
vertible criteria for saying, “This is an X cell; this is a Z cell; this is a 
dead cell.” 
URIST: Will the criterion of ultrastructure contribute something in 
addition? 
PRITCHARD: I think it will help, but we need evidence from many 
different sources; we will have to say where the different criteria 
overlap and congeal into definitive species, like separating out the 
animals of an animal population. One criterion does not, in general, 
enable you to distinguish one species from another. You have to inte- 
grate a lot of criteria before you can say, “This is one species, quite 
distinct from that species.” 
URIST: Dr. Robinson, can you distinguish between a preosteoblast 
and a premuscle cell? The two can be found in adjacent areas in 
every section of bone tissue. 
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ROBINSON: o. 
URIST: There is no ultrastructural characteristic? 
ROBINSON: I am not saying there is no ultrastructural characteristic. 
It is just that I have not studied the di€ference between a preosteo- 
blast and a premuscle cell. 
URIST: Let us say a preosteoblast and a prehematocytoblast. They 
are all right there. 
ROBINSON: Well, I think that one of the things that has fascinated us 
in the study of the haversian canal is that there is really a three-cell 
layer, even in the young canal; there is the endothelial cell, the cell that 
lies under the endothelial cell, and the cell that lies next to the bone. 
The cell that lies between the endothelial cell and the bone cell has some 
characteristics of both, if you want to speak about morphology of fine 
structure of the cytoplasm. 
This is described by Cooper et al. (ref. 25) ,  but we are not sure what 
these slight resemblances mean because, after all, the morphology may 
have something to do with the function of the cell at the moment. 
What I am interested in now is where these osteoblasts can possibly 
come from in many sites in bone; for instance, up in the area where 
new bone is forming on trabeculae of calcified cartilage. Trueta (ref. 
116) has pointed out that the only cell around seems to be the endo- 
thelial cell, and he, I think, stated quite definitely that the endothelial 
cell became an osteoblast. 
PRITCHARD: Many people would not agree that there are no other 
cells around, that the endothelial cell is the only candidate. They 
would point to the mesenchymal population around the blood vessels. 
ROBINSON: Well, we felt quite differently than Trueta did. We felt 
that the endothelial cell might give rise to the precursor of the osteo- 
blast, but we were in doubt as to the origin of the endothelial cell itself. 
Could it be one of the functional forms of a monocyte? 
I would like to ask Dr. Owen about statements in her paper in which 
it was mentioned that thymidine was picked up by the endothelial cells, 
by the progenitor of the osteoblast, also once in a while by the osteo- 
blast, and even by the surface osteocytes, cells which I do not think 
would be expected to divide. I think Dr. Owen referred to Pelc in 
this regard. 
OWEN: I think you are referring to the paper (ref. 112) where we 
were studying the growing surface of young rabbit femur. The osteo- 
blasts are on the bone surface; the precursors of the osteoblasts, termed 
the “preosteoblasts,” are behind the osteoblasts. These latter cells 
were the main region of thymidine uptake at short times after injection. 
They may well have included endothelial cells; we did not try to dis- 
tinguish these. We never found early thymidine labeling of osteocytes. 
Labeled osteocytes were found, but at later times, due to the fact that 
150 Biology of Hard Tissue 
the cells had taken up the thymidine at an earlier stage, probably as 
preosteoblasts. 
BELANGER: Certainly, migration. 
OWEN: Migration, yes. Perhaps you are referring to a second 
paper; there were two papers. Are you referring to the first or second? 
ROBINSON: 1- am referring to the paper by Owen and MacPherson 
(ref. 117). 
OWEN: Yes; that was the second paper. As you know, incorpora- 
tion of thymidine into DNA occurs during the process of doubling 
of the cell’s DNA in preparation for cell division. All cells that have 
taken up thymidine should have divided by about 17 hours after in- 
jection. We found that a certain proportion of the cells that took up 
thymidine did not appear to have divided by one, two, or more days 
after injection. Our evidence came from grain-count studies where 
we showed that a proportion of the cells at later times had the original 
grain count of cells 1 hour after thymidine injection. As yet we have 
not made any further progress on this matter, and I do not know what 
its significance is. 
PRITCHARD: oes this include the osteoblasts? 
OWEW: A small number of osteoblasts do take up thymidine; other 
people have also reported this. However, this could possibly be ex- 
plained in terms of our criterion for distinguishing preosteoblasts from 
osteoblasts. We distinguish in terms of location only so that a labeled 
osteoblast could in fact be a preosteoblast in the wrong location. 
BEEANGER: Dr. Owen, did you not use the double-labeling method 
at one time to show a label in the nucleus and a label in the cyto- 
plasm- let us say, protein synthesis in cytoplasm and nuclear labeling 
from thymidine? 
OWEN: I think you are referring to our experiments using tritiated 
glycine. 
BELANGER: I think what you did was to show incorporation in the 
matrix from cell. 
OWEN: Yes. Glycine is taken up into collagen; Le., glycine is first 
incorporated into the osteoblast and then laid down in matrix collagen. 
In addition, as Dr. Young showed, there was also some uptake of 
glycine into young osteocytes. These are the osteocytes near a grow- 
ing bone surface, and in more recent work l have found that they also 
take up a little RNA. 
YOUNG: RNA precursors? 
OWEN: RNA precursors, at a low rate. 
YOUNG: I think that the terminology has been perhaps a little obscure 
here. I feel that we should recognize in bone four major functional 
states of the bone cell. One of these is a dividing state, which I call - 
the osteoprogenitor, and this osteoprogenitor, the offspring from this 
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cell, can specialize as either osteoblast or osteoclast. If given the 
opportunity, I will try to demonstrate that to you. That is why I feel 
it is misleading to call this dividing cell either a preosteoblast or pre- 
osteoclast because it implies that you know, before it has specialized, 
how it is going to specialize. 
Now, if the osteoprogenitor can specialize as an osteoblast, which 
it can, there must be a stage when it is accumulating the intracellular 
machinery that will ultimately characterize it as an osteoblast. During 
this specialization process, which is a matter of a few hours (ref. 109), 
it will have some of the characteristics of an osteoblast, but will not be 
a fully developed osteoblast. If we wish to use the term “preosteo- 
blast” for this cell when it is in the process of specializing, I do not see 
any objection to that. However, I would like to point out that a prob- 
lem arises if you are observing an osteoblast that is respecializing as an 
osteoprogenitor. You may call it a preosteoblast when it is actually 
postosteoblast. 
We must discuss 
reversibility at some time because it is crucial to the whole problem of 
cell physiology. 
HOLTZER: Can I make a plea that this discussion, which really could 
have taken place 30 years ago, is still taking place, and- 
PRITCHARD: We did not have any tritiated thymidine then. 
HOLTZER: That is it. 
PRITCHARD: This is a big question, reversibility. 
So let us forget the guidelines of 30 years ago 
and focus on Dr. Young’s elegant model. There is a population of 
cells. Some of them can be identified under the microscope, others 
cannot. I think some of the questions raised, “Do they all work?” 
and “How can they be recognized in the process of transforming?” are 
very provocative, but how can they be approached experimentally? 
PRITCHARD: I think we ought to communicate. 
HOLTZER: We have an operational definition: At a given time a 
given cell is engaged in making A, B, and C kinds of molecules. At a 
later time can that same cell engage in making X, Y, and 2 molecules? 
In brief, let us not worry about names; rather, let us be concerned about 
the experimental evidence which shows that before, during, or after a 
given mitosis, a cell synthesizes this or that kind of molecule. So 
many questions we ask cannot as yet be answered in terms of current 
methodologies. 
Let us leave the terminology at this stage by 
agreeing that underneath the fiber layer there is a progenitor layer. 
Then.there is the next layer which the problem is really about; what 
are we going to call this layer, before we get down to the cells that 
everybody agrees on? What are we going to call these intermediate 
cells which do not multiply as fast as those of the other layer. The term 
PRITCHARD: All right. 
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mostly used is “preosteoblast,” but should there not be preosteoclasts 
and prechondroblasts? What should we call the intermediate cells? 
OWEN: I have pointed out some differences that have been demon- 
strated within osteoprogenitor cells, but I do not want to emphasize 
them. For the moment I think Dr. Young’s scheme is an excellent 
working basis: osteoprogenitor cells and the functional cells of bone 
including osteoblasts, osteoclasts, osteocytes, chondrocytes, and so 
forth. However, I am of the opinion that differentiation is probably 
not a one-step process. It is a gradual accumulation of characteristics 
until the fully differentiated cell is achieved. Eventually we will be 
able to distinguish the different states, which I am certain exist, among 
osteoprogenitor cells; but for the moment I propose that we stick to 
Dr. Young’s scheme. 
RAISZ: I would like one point clarified. Is cell division required to 
go from one of these cell types to another? This is the implication 
now, but from things said earlier, I did not think it was true. 
YOUNG: Cell division is required to make new cells. 
RAISZ: That is helpful. 
YOUNG: No. 
OWEN: That is another question, another problem. 
PRITCHARD: Please bear with me for a moment. This question of 
the relationship of these cells to each other and the criteria for differ- 
entiating them is not purely academic. Many advances in bone phys- 
iology depend upon getting the right answers, and we also have to 
establish a firm base for genetic studies. I should like to stress that 
Dr. Young is not the only man in the field so far as these relationships 
are concerned. Frost (ref. 118) has a scheme in which the cells go in 
one direction and all die at the other end, he has no reversibility in his 
system. Other people haie modulation effects, side effects, one cell 
turning into another. Dr. Young’s scheme is a reversible scheme. 
These differences are significant and important. I would like to know 
what the evidence is before we take up the more dynamic aspects. 
BELANGER: I would like to object to the statement just made by Dr. 
Owen. I think the term “osteoprogenitor” was proposed by Dr. 
Young to apply to normal events only. If you have a fracture, for 
instance, you can see that these cells which are supposed to be under 
normal conditions, just progressively becoming bone cells, will now 
start making cartilage in the same site. Therefore I do not think that 
there is, at this moment, a very fixed destiny of the cell. This cell can 
divide. This cell is an ancestor of some kind; but depending on the 
local or general conditions of the organism, the cell could just as well 
turn into a cartilage cell, into a blood cell, or into all sorts of things. 
So I think that the old term “mesenchymal cell” or the term “stem 
It is not necessary to divide in order to go 
from one to the other? 
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cell,” such as is used by Cronkite et al. (ref. 108) in their excellent 
work, does not commit that cell to any specific destiny. 
NICHOLS: I think the thing we really want to know now is whether 
one can identify these cells on a functional basis; and if so, how? 
BELANGER: It is for Dr. Nichols’ benefit, mainly, that I w d d  like 
to answer that question and stress the point about the resting, or let us 
say “lazy” osteoblasts in relation to active ones. Figure 62 shows a 
“lazy” one seen at low power. We can see that it has already been 
growing processes next to the surface bone, but it has a fairly well- 
developed endoplasmic reticulum, and a few processes on the opposite 
side. But the main character of this cell, which distinguishes it from 
an active osteoblast, is the lack of development of the Golgi complex. 
This cell has practically no Golgi apparatus. If one can distinguish 
where, in time, this cell belongs in the lineage of migration of cells after 
FIGURE 62. Osteoblast from tibial diaphysis of I I-day chick embryo. 
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it has picked up thymidine, this cell is not an active osteoblast. For 
some reason it is not manufacturing protein in large amounts, or other 
constituents of bone. It is a resting cell, but it is already a highly 
differentiated cell. 
YOUNG: How do you know it is not synthesizing protein? 
BELANGER: I do not say it is not. I t  does not show that it is active 
at the same rate as the large osteoblasts Dr. Pritchard has described in 
which one can see a very well developed Golgi apparatus and an endo- 
plasmic reticulum with large cisternae. In this cell there are no cis- 
ternae and no Golgi complexes. 
NICHOLS: Dr. Young, when you see osteoprogenitor cells, do they 
take up precursors, such as glycine or proline? 
YOUNG: You show only a tiny slice of one cell. I am not convinced 
there might not be a Golgi complex in the next section. 
BELANGER: This is a low-power thing, and I realize that you have 
not seen the whole cell; but Dr. Nichols asked for a distinction. The 
only distinction I could suggest would be that the Golgi net is small at 
the endoplasmic reticulum. 
NICHOLS: I would like to comment on this discussion because I 
think it is very important for several reasons. I submit that morpho- 
logic criteria, such as presence or absence of rough endoplasmic retic- 
ulum, are not sound evidence in assessing the activity of the cell. The 
mere presence of equipment does not mean that it is being used. 
The time required for a cell to get ready to make protein under a 
stimulus may well depend upon how much of the needed equipment it 
has; perhaps this is differentiation-at least in one sense. The point 
is that there can be various kinds of cells in various stages of activity 
depending on a whole series of stimuli. While it may be quite different 
to equate a given cell to a given job, this is going to be very important 
if we are going to understand (1) how the tissue is formed, (2) how it is 
taken away, and (3) what goes wrong with the system when we get 
sick. 
PRITCHARD: Consider the flattened cells on the surfaces of adult 
bone. If you fracture the bone, these cells have become plump, 
typical osteoblasts and have started to make bone matrix within 12 
hours. So they can get their machinery in top gear in 12 hours. 
FREMONT-SMITH: Are there any tissue-culture studies which would 
throw light on this? Because then you can get moving pictures of 
some of these cells and watch them when they are doing it. Is any 
material on this available? 
URIST: Yes; that has been done. When a piece of bone is put in 
tissue culture, there is an outgrowth of cells that are spindle-shaped 
connective tissue cells, that look like mesenchymal cells, but they 
exhibit a different capacity for development. 
Cellular Differentiation in Bone 155 
FREMONT-SMITH: Do you know where they come from? 
URIST: We assume they come from osteoprogenitor cells. If you 
use a cataract knife to remove a bone explant from tissue culture and 
transplant the outgrowth back into a living rat, the cultured cells will 
differentiate into osteoblasts. Cells that look like undifferentiated 
connective tissue cells can be different insofar as they can exhibit 
osteogenic potency. If one looked at the spindle-shaped cell of the 
outgrowth under the electron microscope I do not know what one 
would see; I do not know anyone who has done this experiment to 
investigate the ultrastructure of the cells of the outgrowth. 
FREMONT-SMITH: Some of the moving pictures of tissue-culture 
cells in the central nervous system, for instance, have changed our 
views so strikingly that I thought maybe this would answer some of 
the questions Dr. Nichols raised. I thought maybe we were using 
the wrong criteria for making decisions as to what a cell can do or has 
been doing. 
NICHOLS: I am not acquainted with those observations so I cannot 
comment, but certainly one of the problems with tissue culture is 
dedifferentiation, which seems to be a particular plague of cultures of 
fibroblasts and connective tissue cells at large. 
Dedifferentiation does occur, after two and 
three generations of cell culture. Eventually the cells can no longer 
make bone. The more recently the cell has had contact with bone, the 
more likely it is to be able to make bone when it is grown out on tissue 
culture and returned to an intact animal. 
FREMONT-SMITH: You mean only after the cells were transplanted 
back? 
URIST: Yes; after the cell has been away from the animal and away 
from the bone for a long time, after the third and fourth generations 
have been cultured and recultured, the cells of the outgrowth lose their 
potency to differentiate into bone after transplantation. 
PRITCHARD: Muller (ref. 119), one of the great pioneers of tissue 
culture, subcultured osteoblasts about 19 times, if 1 remember cor- 
rectly, and yet they kept their potency. This does not agree with what 
you say. The cell may look different, but it keeps its potency. 
NICHOLS: I submit that the cell does not even have to be near bone. 
I remember some experiments by Dr. Huggins in 193 1 ,  in which he 
transplanted bladder epithelium and got bone (ref. 120). 
URIST: That is another interesting problem. 
PRITCHARD: Surely, it depends on the environment. If you can put 
them back into the environment that they came from- 
URIST: Eventually, after many cell divisions, the cell loses osteo- 
genic potency. It may divide 19 times, but eventually it must lose the 
URIST: This is correct. 
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capacity to produce bone. It may be a question of dilution of a genetic 
material or cytoplasmic substance. 
HOLTZER: The main difficulty in this type of problem is cell trans- 
formation, or dedifferentiation, and cell selection. Whether cells in 
culture reversibly or irreversibly alter their metabolic behavior, or 
whether a cell type originally in the minority crowds out the cell type 
being studied, is a very confused issue. This problem can be avoided 
by beginning with a pure population of cartilage cells. Then by com- 
bining autoradiography and biochemical extraction procedures, one 
can at least pose the question of what some cells at a given moment 
are doing. 
For example, without going into details, postmitotic cartilage cells 
taken out of their matrix can be induced to reenter the mitotic cycle 
and, in addition, to begin to synthesize a hyaluronic-acid-like molecule. 
Now, if after a few days they are allowed to aggregate, they cease mak- 
ing DNA and revert to synthesizing chondroitin sulfate. Alternatively, 
if the liberated chondrocytes are maintained as monodisperse cells in 
culture for several weeks and then allowed to aggregate, they do not 
go back to synthesizing chondroitin sulfate that can be detected as 
metachromatic matrix. In short, the chondrocyte’s progeny has a 
fine memory for fabricating molecules required for mitotic activity, 
but its memory for synthesizing chondroitin sulfate, under certain 
conditions, is considerably more fuzzy. 
PRITCHARD: It depends on the environment. If you can put them 
back into the environment that they came from- 
HOLTZER: We did that and in the “normal” environment of the 
chorioallantoic membrane or the somite, they do not revert to making 
chondroitin sulfate. On the other hand, under conditions we have not 
used, they might resume their original or, for that matter, a quite novel 
metabolic activity. For, although the story is by no means complete, 
experiments on nuclear transplantations and on virus fused cells all 
point to a great deal of “reversible” behavior in mature cells. 
URIST: Perhaps it is necessary to assume that the capacity to produce 
bone is lost only temporarily. Every connective tissue cell in the body 
may have the capacity to make bone, especially if it undergoes a series 
of mitotic divisions and is in a conducive environment. 
PRITCHARD: That is an act of faith. 
URIST: We will discuss the subject of potency again when we get 
to the induction systems. 
Every connective tissue cell came from an original cell, so it is just 
a question of how far back we want to go to retrace the development 
from the unspecialized connective tissue cell to the osteoprogenitor 
cell. 
PRITCHARD: Why do not liver cells make bone? 
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NICHOLS: Could we ask Dr. Holtzer to tell us more about his car- 
tilage cell? Fundamentally, I agree with him; we ought to find out 
what cells are doing. 
PRITCHARD: Dr. Holtzer says that in 12 hours they start making 
hyaluronic acid instead of chondroitin sulfate. Do they mike col- 
lagen up to then? Could we see his figures? 
HOLTZER: Many of the issues that have been discussed can only be 
analyzed critically with a homogeneous population of cells. Bone, at 
best, consists of a variety of cell types, and any measurements either 
of whole bone or on cells from bone, of necessity, involve measuring 
changes in the activity of more nonbone cells than true osteocytes or 
osteoblasts. By stripping away the adhering connective tissues from 
embryonic cartilages and treating such cartilages with trypsin to digest 
the matrix, a quite pure population of chondrocytes can be obtained; 
with care, well over 99 percent of the liberated cells are differentiated, 
working chondrocytes. Now, what these liberated postmitotic chon- 
drocytes, which are making chondroitin sulfate and collagen, will do 
after removal from their matrix depends on how they are grown. In 
different microenvironments they synthesize different kinds of mole- 
cules. If, as already mentioned, liberated chondrocytes are spun down 
into a smaller cluster, they remain postmitotic and continue to syn- 
thesize chondroitin sulfate and collagen (ref. 12 1). Alternatively, if 
plated on top of a clot, they spread and are induced to reenter the 
mitotic cycle. 
Figures 63, 64, and 65 show that in addition to making DNA and 
the other kinds of molecules, multiplying cells synthesize, dividing 
chondrocytes, and their progeny synthesize a polysaccharide rich in 
glucosamine, this polysaccharide is not sulfated and has the electro- 
phoretic mobility of hyaluronic acid. Neither the in vivo chondro- 
cytes from 10-day embryos nor the liberated chondrocytes spun down 
into pellets synthesize this hyaluronic-acid-like polysaccharide. 
With time these cultures become more dense owing to cell multi- 
plication. Correlated with this is a shift in the kinds of polysaccharides 
these cells produce. A polysaccharide appears with the mobility of 
hyaluronic acid but with a high galactosamine-to-glucosamine ratio 
(ref. 122). In addition, large amounts of chondroitin sulfate are made 
in the new dense cultures. 
If the progeny of chondrocytes are grown for a considerable time 
in vitro and then challenged to display their capacity for synthesizing 
chondroitin sulfate, the results again depend on the nature of their 
in vitro microenvironment. For example, as shown in figure 66, if 
grown in reasonably high densities for four generations and then spun 
down and grown as cells in a pellet, the progeny of chondrocytes make 
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FIGURE 63. Freshly liberated chondrocytes (FLC) were spun down into a 
pellet and organ cultured in 355. The tissues were harvested on different days 
and the counts in chondroitin sulfate (CSA) determined. Under these conditions 
there is no net synthesis of DNA and the chondrocytes continue to make chon- 
droitin sulfate. In  other experiments it has been shown that they continue to 
make collagen as well. 
much less chondroitin sulfate per unit of DNA than freshly liberated 
chondrocytes grown under identical conditions. 
To check whether this diminution is a result of all cells making less 
chondroitin sulfate per cell or whether some cells are not producing 
while a minority are working hard, we performed cloning experiments 
(ref. 123). Without going into details of culture procedures, we grew 
in the same dish in the presence of 14C-glucose, colonies of matrix 
producers and colonies of dedifferentiated, or transformed, chondro- 
cytes. The matrix producers synthesized chondroitin sulfate, and the 
transformed cells produced a different spectrum of polysaccharides. 
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FIGURE 64. 
persed cells. 
of culture, which levels off after a certain density is reached. 
the cells resume the synthesis of chondroitin sulfate. 
FLC cells were plated in milk bottles on top of a clot as monodis- 
There is an abrupt rise in DNA synthesis during the first 4 days 
About this time 
From this we suspect that the chondroitin sulfate made in the fourth- 
generation cultures (figs. 66 and 67) might be made by a minority of 
the cells in the cultures; the majority are dedifferentiated, or trans- 
formed, chondrocytes. Thus far we have not been successful in shunt- 
ing the dedifferentiated, or transformed, chondrocytes back into 
chondroitin sulfate producers. 
When 
chondrocytes are cloned on plastic they may organize into an epithelial 
sheet which morphologically and functionally serves as an in vitro 
perichondrium. Cloned cells on plastic divide and, because daughter 
cells do not migrate, establish compact epithelial colonies. By mitosis, 
new cells are added to these tight little islands both in the plane of the 
These clonal experiments (ref. 121) led to another finding. 
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FIGURE 65. FLC cells were grown as monodispersed cells in the presence of 14C-glucose. 
After Pronase digestion the polysaccharides were separated in pyridinium formate on 
cellulose acetate. Observe the prominent peak where hyaluronic acid would run. On 
hydrolysis this peak yields a fraction with a high glucosamine-to-galactosamine ratio. 
substrate and also displaced upward from the substrate. The dis- 
placed cells become rounded and synthesize chondroitin sulfate. The 
same cells on a fibrin clot spread, do not form epithelial colonies, and 
do not synthesize chondroitin sulfate in appreciable amounts. If, 
after growing on a clot for five generations, these cells are cloned on 
plastic, they fail to form epithelial colonies and fail to synthesize de- 
tectable amounts of chondroitin sulfate. 
The central question to which these kinds of experiments are directed 
is, What kinds or species of molecules can a cell make concurrently? 
For example, I do not believe that a cell can make myosin and albumin 
simultaneously, that the cytoplasmic-nuclear conditions required for 
the one preclude the fabrication of the other. On the other band, a 
cell synthesizing myosin does make the cytochromes, dehydrogenases, 
myoglobin, ribosomal proteins, glycogen, and so forth. But it is by no 
means clear that all kinds of molecules found in a given cell can be made 
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FIGURE 66. An aliquot of FLC cells was spun down into a pellet, the remainder 
grown as cells in monolayers. After 5 days in a monolayer situation, the cells 
were again divided into two groups: one grown as pellets, and the other as mono- 
layers. After another 5 days the monolayers were again divided into two groups: 
pellets and monolayers. This was repeated for a third time. The values shown 
in this figure are for the pellets of the first, second, third, and fourth generations 
of cells. Clearly the amount of chondroitin sulfate made by cells in pellets 
varies with their previous in vitro history. 
concurrently. For example, by definition a cell only makes DNA 
during S. During G-1, G-2, or M, a cell does not synthesize DNA, 
although clearly it is busy synthesizing other molecules. Are, in fact, 
all the mitochondrial enzymes, RNA's, and structural proteins made at 
any time in the mitotic cycle or at any time in the life history of the 
cell? Recently, we have shown (refs. 124 and 125) that myosin is 
not synthesized during S, G-2, M, or even during the first 3 to 5 
hours in G-1. 
Returning to pure populations of chondrocytes, we would like to 
know what kinds of molecules they or their progeny can make and how 
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FIGURE 67. 
saccharides analyzed by chromatography. 
polysaccharide to total polysaccharide is less in the subcultured cells. 
FLC cells were grown for three subcultures as monolayers and their poly- 
Note that the relative amount of sulfated 
seemingly “trivial” differences in their microenvironments induce them 
to alter their typical products? 
At this point we are not convinced that the genetic controls regulat- 
ing the synthesis of, for example, amino acids or the enzymes associ- 
ated with oxidative phosphorylation, are the same kind of controls 
that regulate the production of cell-unique molecules like chondroitin 
sulfate or myosin. 
ROBINSON: Can you give these cells messages so that they will 
change- 
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HOLTZER: We have tried. We put them back into the animal, as 
ROBINSON: I was thinking of the classic experiments with bacteria. 
HOLTZER: No; there is no tissue system in which anybody has in- 
structed cells to make anything. I would make that staternmt cate- 
gorically; I said tissue cells. 
NICHOLS: But you have informed these cells, because when you 
plated them you were placing them under a new set of conditions, if 
you like; you were subjecting them to a new set of stresses which was 
interpreted by the cells as a stimulus to do something different from 
what they were doing before. This is an extremely important point 
that we have ignored. For example, how does a bone cell know that 
it has been in a fracture site? 
you suggested, and they do not go back into the cartilage. 
HOLTZER: That is a beautiful question. 
PRITCHARD: Have you taken these cells and tried to cluster them 
HOLTZER: Yes. 
URIST: We have done a similar experiment. We have transplanted a 
pack of chondrocytes back into the donor, and the cells do not resume 
chondrogenesis. 
MCLEAN: I want to throw a monkey wrench into this machinery we 
have been talking about. It is not mine but something that Frost (ref. 
1 18) has published; he calls it a concept. He starts with a line of stem 
cells, and then some of these stem cells divide. He has introduced the 
idea that every time a stem cell divides, it produces an undifferentiated 
reserve cell and simultaneously produces one differentiated cell. For 
instance, a stem cell could give rise to an osteoblast and another stem 
cell. 
PRITCHARD: I would like Dr. Young to comment on this because he 
has been concerned with these relationships as much as anyone else; 
and Dr. Owen, too. 
HOWELL: Would Dr. Young also comment on whether cell death is 
part of this picture? 
PRITCHARD: That these eventually finish their life cycle and die. 
YOUNG: I think most of us who have been studying normal bone 
growth have seen practically no cell death. I would rather address 
my comments to the important point, which grew out of Dr. Holtzer’s 
presentation and was seconded by some others, that the critical infor- 
mation for these various activities is already in the cell, coded in its 
DNA. One need not provide the cell with information-bearing macro- 
molecules, as in the transformation experiments, to call forth from it 
potentialities which it might not have shown in the living organism. 
I prefer to think, although we are not down to control mechanisms, 
that the effect of the microenvironment is among the most important 
again? 
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I-IGURE 68. 
PAS-hematoxylin stain. 920 X. 
genitors in prophase near the center. 
Photomicrographs of sections of tibial methaphysis of I-week-old rats. 
Note the two osteopro- (a )  Osteoblasts and osteoprogenitors are seen in this field. 
( b )  An osteoclast and several osteoprogenitors are visible. 
(c )  One hour after injection of JH-thymidine. Several osteoprogenitors are labeled, 
indicating DNA synthesis prior to mitosis. Osteoblasts are unreactive. Autoradio- 
graph. 
Labeled nuclei are seen in osteo- (d) One hour after injection of SH-thymidine. 
progenitors, but not in the osteoclast (center). 
Labeled nuclei are now found in 
osteoclasts, indicating that these cells are derived through specialization of osteopro- 
genitors. Autoradiograph. 
Autoradiograph. 
( e )  Sixteen hours after injection of JH-thymidine. 
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factors in the control mechanism. While on this point I would like to 
show some figures. 
One of the requirements for working with tritiated thymidine is to 
be able to classify the cells. Figure 68(u) shows the cells, the osteo- 
blasts, that one sees around the bone. However, there are also pale- 
staining, rather fusiform cells, which I call osteoprogenitors. 
Figure 68(b) is of another region and shows an osteoclast; again there 
are several of the pale-staining cells, the osteoprogenitors. 
Work with tritiated thymidine has been repeated in many labora- 
tories. It shows that osteoblasts and osteoclasts are incapable of re- 
producing themselves. They do not take up thymidine, they do not 
synthesize DNA, and they do not divide (refs. 126 and 127). 
However, shortly after the injection of tritiated thymidine, we find 
that the cells which are synthesizing DNA and will divide are the 
pale-staining cells, the osteoprogenitors, as shown in figure 68(c). The 
specialized osteoblasts rarely take up thymidine. 
Figure 68(4  is of another field and shows an osteoclast; again, 
synthesis of DNA and preparation for cell division are occurring in 
the pale-staining osteoprogenitors. Shortly after the completion of 
DNA synthesis, these cells divide. We can keep track of them because 
they are radioactive. 
Figure 69 is a scheme of the cell cycle. We have made radioactive 
those cells that were in the DNA synthetic period (S) at the time of 
injection; and if we now, in a series of intervals thereafter, continually 
sample this histologically recognizable mitotic compartment (M), we 
will see the passage of cells from DNA synthesis into mitosis. There 
is a peak that represents this division, which has occurred within a few 
hours after DNA synthesis; some of these cells will still continue to 
divide (refs. 109 and 128). 
This can be determined in any number of ways. One simple wav 
is to watch them come through a second time. They are becoming 
more uniformly distributed temporarily throughout the cycle. 
PRITCHARD: This percentage of labeled cell refers to what total 
population? 
YOUNG: We searched the region of bone for mitotic cells and re- 
corded the percentage of those that are radioactive. 
PRITCHARD: Relative to every cell in the neighborhood? 
YOUNG: No; just looking at the dividing cells. It is a percentage 
of all the mitoses that were radioactive, and at this interval every 
dividing cell is radioactive. 
That is 
why they were synthesizing DNA in the first place; they were getting 
ready to divide. Some of them continue to divide. Others, however, 
change their specialization, reorganizing their metabolic machinery 
The point is that the labeled progenitor cells do divide. 
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FIGURE 69. A schematic representation of the cell cycle in a dividing popula- 
tion. Interphase is subdivided into GI.  DNA synthesis (S), and G ,  periods. 
Cells engaged in DNA synthesis in the presence of 3H-thymidine become 
radioactive. These labeled cells may then be followed through the histologically 
recognizable mitosis (M) phase during subsequent hours. 
to become the specialized cells that we discussed previously; so that 
within a few hours, we can begin to detect radioactive nuclei in osteo- 
blasts. Although the thymidine is available for only about an hour, 
none of these cells is initially labeled. Only after the osteoprogenitors 
have had time to specialize do we begin to pick up increasing numbers 
of labeled nuclei in osteoblasts. 
Within a few hours one begins to find labeled nuclei also in osteoclasts 
(fig. 68(e));  this demonstrates that the osteoprogenitors can continue to 
divide or, depending upon the microenvironment in which they find 
themselves, may specialize as either osteoblasts or osteoclasts. 
Ultimately, some of the osteoblasts become trapped in bone, in 
which case we then see labeled nuclei in the same cell; but now we call 
it an osteocyte. 
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I made the statement that osteoprogenitors are equally capable of 
specializing as osteoblasts or osteoclasts, and I would like to try to 
document that in several ways. (The quantitative data are given in 
detail. by Young (ref. 128).) In young growing rat bone, the percent- 
age of progenitor cells initially labeled is on the order of 25. :5 ,  and 5 
percent in metaphysis, endosteum, and periosteum, respectively. 
If we chart the gradual appearance of labeled nuclei in osteoclasts, 
we find that in the metaphysis, the proportion peaks and will not exceed 
about 25 percent, in the endosteum it does not exceed 15 percent, and 
in the periosteum, 5 percent. The same analysis can be made for 
osteoblasts. The numbers are even more convincing. In the metaph- 
ysis the proportion peaks at about 25 percent, in the endosteum at 
about 15 percent, and in the periosteum, at about 5 percent. 
In an effort to demonstrate that these cell specializations can be af- 
fected by the microenvironment, which is not a very daring statement, 
we can alter the environment one way or the other with different ex- 
perimentally induced changes. In this regard, I have investigated the 
influence of parathyroid extract (fig. 70(a)).  The remarkable increase 
in bone resorption in the treated animal is accompanied by rapid 
changes in cell specialization. 
At the beginning of the experiment in the young rat, we see the 
normal picture (fig. 70(b)) with large numbers of osteoblasts. Within 
4 or 5 hours after injection, we begin to see changes in the morphology 
of the cells. At 12 hours (fig. 70(c)),  some cells can stili be classified 
as osteoblasts, but some are beginning to assume the morphology of 
the progenitor cells. 
A few hours later (fig. 70(6)) there are large numbers of osteoclasts 
forming by specialization from the precursor. There are essentially 
no osteoblasts under these high doses, but there are a large number of 
osteoprogenitors. 
At the height of the effect of the hormone, which in these young rats 
is about 22 hours after injection (fig. 70(e)),  we find large numbers of 
osteoprogenitors and no osteoblasts. When we provide these osteo- 
progenitors with tritiated glycine, we may recall how greatly glycine 
was concentrated on osteoblasts (see fig. 60). In contrast, these cells 
not only look like osteoprogenitors, they are behaving like osteo- 
progenitors, as shown by their diminished utilization of the labeled 
glycine. 
PRITCHARD: May I ask what are the cells along the spicule if they 
are not osteoblasts? 
YOUNG: I think by the absence of any cytoplasmic basophilia what- 
soever and by their very low utilization of glycine- 
PRITCHARD: They are simply not working. They are inactive osteo- 
blasts. Why not? 
In fact, they are osteoprogenitors. 
311-496 0-68-12 
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Figure 70. Effect of parathyroid extract (PTE) on rat tibias. 
(a) Roentgenograph of tibias of 4-week-old rats. Control (left) and sacrified 48 hours 
after large dose of PTE (right). Note the marked resorption in metaphyseal region. 
Photomicrographs of sections of tibial metaphysis of 1-week old rats. PAS-hema- 
toxylin stain. 870X. 
(b) Prior to onset of treatment; large numbers of osteoblasts are present. 
(c) Twelve hours after PTE. Osteoblasts in process of returning to osteoprogenitor 
state under changed microenvironment. 
(d) Eighteen hours after PTE. Most of bone cells are now specialized as either 
osteoprogenitors or osteoclasts. 
(e) Twenty-two hours after PTE and 30 minutes after injection of 3H-glycine. Osteo- 
progenitor cells, formed through respecialization of osteoblasts under the influence of 
PTE, fail to concentrate labeled glycine as they did in the osteoblastic state. Auto- 
radiograph. 
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YOUNG: I prefer to call them osteoprogenitors. If, in the same ex- 
periment, we provide these cells with tritiated thymidine, all of these 
cells appear to be in the osteoprogenitor state. 
Table IX is an effort to put this effect in quantitative terms. The 
grain-count ratio represents, in a glycine-treated animal, the ratio of 
silver grains over osteoblasts compared with those over osteoclasts. 
As I tried to demonstrate earlier, there is an enormous preponderance 
of glycine utilization in osteoblasts as compared with osteoclasts. 
TABLE IX 
PERCENTAGE OF 3 H - T ~ ~ ~ ~ ~ ~ ~ ~ - L ~ ~ ~ ~ ~ ~  NUCLEI IN OSTEOBLASTS A N D  OSTEOCLASTS 
IN RIBS AND TIBIAS OF RAT a 
Osteoblasts Osteoclasts 
Experimental data 
Normal animals ............................................. 23 
PTE, given 1 to 7 hours after 3H-thymidine 
injection., ................................................. 
PTE, given 12 to 24 hours before 3H-thymidine 
injection ................................................... 26 
Averaged percentages, taken from data reported by Young (refs. 109 and 1 I I ) .  
Parathyroid extract is given at the beginning of the experiment. 
The rats are sacrificed at different intervals thereafter. As the osteo- 
blast undergoes morphologic changes back to the osteoprogenitor 
state, there is a rapid decrease in this physiologic measurement of the 
protein synthetic activity of these cells. At about 22 hours after injec- 
tion the cells look like osteoprogenitors, behave like osteoprogenitors 
with respect to thymidine, and behave like osteoprogenitors with re- 
spect to glycine. One is led to conclude that they are indeed osteo- 
progenitors. 
If we allow the animals to recover, within about 2 days after the height 
of the effect of the parathyroid extract, the cells will have returned to 
their normal behavior. The osteoblasts are repairing the damage; and 
throughout these rapid changes in cell specialization, there is no ob- 
servable increase in cell death. I think this table is an important one. 
The experiments pose the following two questions. Are the progenitor 
cells capable of specializing as osteoblasts or osteoclasts? Can we 
influence this specialization by changing the microenvironment of the 
cells? I think the answer to both of these questions is “Yes.” 
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If the normal animal, the rat in this case, is injected with tritiated 
thymidine, the initially labeled cells are the osteoprogenitors. If we 
allow the animal to survive to a day or so after injection, we find that 
some of the osteoprogenitors have specialized as osteoclasts and others 
have specialized as osteoblasts, depending upon their location in the 
bone and the microenvironmental stimuli which were acting upon 
them. 
If, instead, we follow the thymidine treatment by a large dose of 
parathyroid extract, we find that, a day or so later, large numbers of 
the initially labeled osteoprogenitors have specialized as osteoclasts. 
Very few osteoblasts have been formed under these conditions of high 
levels of parathyroid extract in the cellular environment. 
In the third experiment, we first pretreat the animal with parathyroid 
extract to induce the osteoblasts to revert to the osteoprogenitor state. 
If, at that time (when the bone is filled with osteoclasts and progenitors) 
we provide the animal with thymidine to label the osteoprogenitors, 
and then allow it to recover, we find that during the recovery period the 
cells preferentially specialize as osteoblasts. 
So, I think that these are different functional states of the same cell, 
and that the specialization of the progenitor cell in either one or the 
other direction (as well as in various additional directions which I have 
not had the opportunity to discuss), is determined by the immediate 
microenvironmental circumstances in which the cell finds itself. 
One is the 
reversibility of this chain of cells, and the other is the effect of para- 
thyroid hormone on the cell population. I do not know whether Dr. 
Owen wants to say anything about the first question of reversibility- 
OWEN: No. 
URIST: Dr. Pritchard has made two important points this morning; 
one, that there is a classification problem; the other is the target cell 
for hormones that affect bone. Is the progenitor cell the target cell for 
parathyroid hormone? What is the target cell for thyrocalcitonin? 
PRITCHARD: There are two important concepts here. 
I think Dr. Young's experiments are very elegant. 
PRITCHARD: 1 think Dr. Talmage has some ideas on this. 
TALMAGE: I have a few figures. 
URIST: First, I would like t'o ask Dr. McLean to show his figure; 
MCLEAN: I would like to ask Dr. Young, are these experiments all 
YOUNG: Yes. 
MCLEAN: I would like to point out that the reaction of the rat to para- 
thyroid hormone is different from that of any other mammal that I 
know anything about. It is possible with relatively low doses of 
parathyroid extract to produce this state of hyperostosis, to make I 
everything differentiate into osteoblasts without ever going through 
there is just one. 
on rats? 
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the stage of increased resorption and increased osteoclastic differen- 
tiation. 
YOUNG: With repeated low doses of beef parathyroid extract, experi- 
mental animals may produce antibodies against the foreign protein, 
while the chronic doses may also inhibit the endogenous pxathyroid 
secretion (ref. 129). 
MCLEAN: The only thing 1 am saying is that your statistics are for 
the rat, and that represents a different cycle from what one will find 
in any other animal. 
YOUNG: The absolute numbers of how many progenitor cells are 
labeled is unimportant; it does not matter. Parathyroid extract is 
used here only as a tool to demonstrate the interconversions of the 
cells, which can be demonstrated in many ways. I was not studying 
the effect of parathyroid extract from the standpoint that Dr. Talmage 
might be. 
MCLEAN: My point is that this selective differentiation into osteo- 
clasts or osteoblasts according to the time that you give the para- 
thyroid extract is something special for the rat. 
YOUNG: I do not believe that is true, Dr. McLean. The formation 
of increased numbers of osteoprogenitors and osteoclasts in response to 
a single, large dose of parathyroid extract is very striking in the young 
rat, but is by no means unique in this animal. For example, it has also 
been observed in young guinea pigs (ref. 130), mice (ref. 131), dogs 
(refs. 132 and 133), and pigeons (ref. 134). 
The preferential formation of osteoblasts during the recovery phase 
after a single, large dose of parathyroid extract (refs. 1 1  1 and 135) rep- 
resents a return toward the normal condition. 
On the other hand, if small doses of the extract are repeatedly ad- 
ministered to the rat, it is indeed possible to obtain a preferential and 
exaggerated formation of osteoblasts without previous increase in 
osteoclast formation (ref. 136) or following a transient increase in the 
numbers of osteoclasts (refs. 129, 137 and 138). A similar phe- 
nomenon has been reported in the mouse (ref. 139), indicating that the 
rat is not unique in this respect either. 
ROWLAND: Dr. McLean, do you have experimental evidence for 
other species to contradict these experiments? 
MCLEAN: Yes. Years ago, when we were working very actively 
on parathyroid extract, we tried to reproduce these phenomena in 
other animals. We ran through the whole gamut of experimental ani- 
mals. We never saw this hyperostosis, as we were calling it then, 
except in the rat. 
YOUNG: I believe the significant thing about these experiments is 
the demonstration that these cell interconversions take place. If 
we set aside parathyroid extract and looked at the work that came out 
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of your laboratory, Dr. McLean, some of the early work on cell inter- 
conversions in birds during the egg-laying cycle, we would find these 
studies demonstrated precisely the same thing, the interconversion 
of the cells of the bone series. The osteoprogenitors were at that time 
called, I think, reticular cells. 
MCLEAN: But that was not parathyroid extract. 
YOUNG: No; it was not, but it demonstrated the same basic phe- 
nomenon of cell respecialization which to me is the most important 
point. 
During the experiments we did many 
years ago (ref. 140), we ran into a phenomenon, also peculiar to the rat, 
of cell death under the influence of large doses of parathyroid extract 
(see fig. 1 1  1). 
We observed osteocytes with pyknotic, or disintegrated, nuclei in 
rats 12 hours after intraperitoneal injection of 1000 units of PTE, a 
highly toxic dose; we were quite excited about this at the time. We 
thought it was the mode of action of the parathyroid hormone (ref. 133). 
We never were able to duplicate this, however, in any other animal 
(ref. 135). 
In animals in the same series, this effect was followed by the stage 
of hyperostosis, new bone building, and differentiation of large numbers 
of osteoprogenitor cells into osteoblasts. The first stage is osteo- 
clastic with the peculiar phenomenon of cell death. 
Now, Dr. Talmage. 
MCLEAN: I agree with that. 
URIST: Thank you. 
FREMONT-SMITH: You must explain why my tissue culture idea is 
a red herring as well as a grunion. 
TALMAGE: I would like to leave it to Dr. Raisz to explain the reasons 
tissue cultures using bone are subject to misinterpretation, since he is 
an expert in this field. The primary problem is that as yet no one has 
been successful in getting a pure culture of one type of bone cells. 
Using cartilage, the situation may be different; so discussions based on 
tissue culture of cartilage cells may not be apropos to bone problems. 
But I would like to change the subject now, and discuss the influence 
of parathyroid hormone on osteoclasts. Let me say at the beginning 
that all our work was done using rats. The fact that experts have 
questioned the use of rats because the bone of this species is different 
from that found in either man or dog actually bolsters my argument. 
My primary thesis is that the effect of parathyroid hormone is not on 
osteoclasts, but on the formation of osteoclasts. Since the rat is the 
only species in which one can really show this action of the hormone 
on osteoclasts, this bolsters, even further, my argument that calcium 
homeostasis is not a function of the osteoclast. However, the data 
which I would now like to present are a demonstration of the site of 
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action of the parathyroid hormone in stimulating the production of 
osteoclasts in the rat. 
URIST: What is the target cell for parathyroid hormone? 
TALMAGE: It is the mesenchymal cell. In the matter of terminol- 
ogy, we feel that because the term “mesenchymal cell” is an older term 
it should have preference; we should use the older terms unless we 
have good reasons for changing them. Otherwise, I do not object to 
Dr. Young’s “progenitor” cells. 
The first point is to demonstrate, what all of us must know, that in 
the rat there is a marked effect of parathyroid hormone on osteoclast 
production. 
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[From Talmage et al. (ref. 141); reprinted by permission of the publisher.] 
Methods of increasing osteoclast numbers in the metaphysis of the femur. 
Figure 71 is from an earlier publication (ref. 141). It merely recalls 
for you the fact that one can quantitate the increase in osteoclasts in 
the metaphysis of the femur of the rat as a function of parathyroid 
activity. The normal osteoclast count is given at the left. After 
stimulation by peritoneal lavage with a calcium-free rinse, which is one 
of the best ways to increase endogenous production of parathyroid 
hormone, it is easy enough to show that there is a direct relation be- 
tween the number of osteoclasts and endogenous parathyroid secretion. 
Another method for stimulating secretion is to nephrectomize the 
animal. This, because of the subsequent rise in phosphate, causes a 
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decrease in calcium and therefore a stimulation of the animal’s para- 
thyroids. This increases the osteoclast count. 
The method by which we produced the largest increase in number 
of osteoclasts, as the result of increasing the animal’s own endogenous 
hormone production, was to use a calcium-free lavage containing 
fluoride. This fluoride produced a decrease in the solubility of the 
bone mineral. This resulted in an increased stimulus to the para- 
thyroids. With this background, let us look at the source of these 
new osteoclasts. 
Group 
TABLE X 
:$H-THYMIDINE INJECTION 
[Adapted from Talmage et al. (ref. 14 I ) ]  
EFFECT OF PERITONEAL LAVAGE ON PERCENT NUCLEI LABELED 48 HOURS AFTER 
Osteoclasts Osteoblasts 
I I 
PTX, lavaged a.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Average of all groups: 
Osteoblast: 18.8 k 0.91 
Mesenchymal cells: 6.3 20 .48  
11.3 2 0.44 
I 
20.2 f 1.01 
18.0 20.68 
20.8 k 0.66 
19.3 k0 .68  
The data in table X are based on Dr. Young’s work. Dr. Young 
just demonstrated that 48 hours after tritiated thymidine injection, the 
labeling of mesenchymal cells goes from a high of about 25 to 30 
percent back down to 6 percent. Table X indicates that our data 
substantiate this. Also, by that time, the percent of labeled osteoblasts 
is up to 18 percent, and the osteoclasts up to 10 percent. These fig- 
ures agree with those given by Young. 
Now, if 48 hours after 3H-thymidine injection, we produced a marked 
increase in the number of osteoclasts by an 8-hour peritoneal lavage, 
we should be able to determine if the osteoclasts were derived from 
osteoblasts. If so, the percentage of nuclei labeled would have to 
end up somewhere between the starting percentage for the two types of 
cells. If they were to come directly from mesenchymal cells alone, one 
would expect labeling to be between 10 and 6 percent. But you will 
see that the number of osteoclasts that were labeled after this sudden 
burst of production of osteoclasts dropped below both that for the 
original osteoblasts and for the mesenchymal cells (ref. 141). 
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Mesenchyme 
cells 
This threw us into a quandary, as we had been hoping to show that 
these new osteoclasts came from mesenchymal cells. However, if 
one assumed that most of the mesenchyme cells that produced new 
osteoclasts had to first go through mitosis, this would dilute the label 
sufficiently so that the radioactivity of thymidine would not be de- 
tectable in the osteoclasts. 
While we had eliminated the osteoblast, we did not feel we had 
eliminated mesenchyme cells, so we shifted, then, to mesenchyme 
cells and a study of the uptake of tritiated cytidine. 
TABLE XI 
EFFECT OF PARATHYROID STIMULATION ON PERCENT NUCLEI LABELED 30 MINUTES 
AFTER 'jH-CYTIDINE INJECTION 
[Adapted from Talmage et al. (ref. 141)] 
Group 
A. Nonlavaged: Intact 
8. Lavaged: 
............................................ 16 hours, intact 
16 hours, PTX a. . .  ......................................... 
Osteoblasts: 9.6 2 0.59 
Osteoclasts: 4.1 20.49 
Osteocytes: 1.2 & 0.33 
10.2 20.69 
18.220.70 
20.2k0.69 
11.5 k0.87 
PTX = parathyroidectomized after the eighth hour. 
Table XI demonstrates the labeling of mesenchyme cells with triti- 
ated cytidine one-half hour after injection (ref. 141). We used the %- 
hour period because at that time the cytidine is still in the nucleus. 
Examination of these data demonstrates that the stimulus for increas- 
ing endogenous parathyroid hormone secretion produced by the 
peritoneal lavage technique caused a doubling of the percentage of 
mesenchyme cells labeled. This could be inhibited by parathyroid- 
ectomy. At no time could we see any effect on the labeling of other 
cells; that is, the osteoblasts, the osteoclasts, or the osteocytes. There- 
fore, we assume that parathyroid hormone must have been affecting 
the RNA turnover in mesenchyme cells. 
PRITCHARD: You did not have any difficulty in deciding which was 
a mesenchyme cell and which was not? 
TALMAGE: I am sure we have the same difficulty that everybody 
else has. In our study we call mesenchyme cells the large group of 
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Group 
Controls, nonlavaged (12). .............................................................. 
Controls, lavaged 8 hour 
PTX, lavaged 8 hours (6) 
AMD, injected 8 hours before lavage (6) 
AMD, added to lavage rinse (6) 
......................................... 
........................................................ 
Count 
23.721.2 
53.821.7 
32.6+- 1.6 
37.1 k4.2 
56.6 2 4.0 
Numbers in parentheses indicate number of animals. 
The data in table XI1 back up this’ assumption (ref. 142). In our 
lavage system, when we added actinomycin D to the lavage fluid, it 
caused a fall in the rate of calcium removal by the fourth or fifth hour. 
The important point here is that adding the drug to the fluid did not 
prevent the normal increase in osteoclasts which occurs with lavage. 
Normal increase is between 50 to 100 percent in 8 hours. When, 
however, the drug is given 8 hours prior to the start of the lavage, it 
prevents this increase in the number of osteoclasts formed. 
This suggested to us that whatever parathyroid did, it did immediately, 
before actinomycin D could knock out RNA production. Despite 
the presence of the drug, the simultaneous stimulation by endogenous 
hormone was still able to produce osteoclasts. I think this is a very 
important consideration, as it indicates the rapidity of the action of the 
hormone. 
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Group 
....... Control animals 
239Pu, 24 hours ........ 
Control, lavaged.. ..... 
239Pu, lavaged.. ........ 
Number of Osteoclasts Number of Mesenchyme cells 
animals per field animals 3H-thymidine- 
labeled, percent 
3 19.2 k 0 . 6  
7 35.422.3 3 a 12.0Ifr0.5 
11 33.0k1.5 
14 54.1k2.6 ........ 
12 b 4 1 . 9 ~ l . 6  ........................... : ................ 
Table XI11 demonstrates the effects of plutonium (ref. 143). We 
had discovered that if plutonium is injected into an animal, the first 
effect produced in 24 hours- 
BAUER: How much? 
TALMAGE: The dose was ample, 1 mg/100 g animal weight. I 
am not trying to stress long-range effects of plutonium. An immediate 
effect of plutonium is that by 24 hours the bone was unable to respond 
to the stimulus of endogenous parathyroid secretion, at least in that no 
osteoclasts were found following peritoneal lavage. This is illustrated 
in table XIII. Also summarized are data on the inhibition by plu- 
tonium, under these conditions, of the uptake of 3H-thymidine by 
mesenchyme cells. These data would again indicate that the effect 
of parathyroid hormone is on mesenchyme cells. 
I would like to discuss figure 46 in more detail and with a different 
emphasis. It represents some of our recent work and is preliminary 
data. 
In these experiments the rats were subjected to peritoneal lavage 
for up to 8 hours. Following lavage, the bones were dissected out as 
fast as possible. It was only 8 minutes from the time the animal was 
killed until the bone was placed into the incubation flask. Tritiated 
cytidine and thymidine were added to the serum and incubated with 
the bones for 1 hour. RNA and DNA were extracted and the specific 
activities were determined. 
I would like to emphasize the point that the parathyroid stimulation 
needed to last only 20 minutes to produce a very marked increase in 
the uptake of 3H-cytidine by RNA. This increase was seen only in 
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the metaphysis during the early hours, but later during the lavage 
both the metaphysis and the diaphysis were affected. 
The fact that the early stimulation is in the metaphysis suggests 
that we are seeing effects primarily in the large population of mesen- 
chyme cells which are located in this area of bone. 
I would like to use figure 46 to demonstrate one other point which 
we have not yet proved statistically but which may become important. 
In this figure, the 3H-cytidine uptake by the two types of bone in 
control rats is shown as the baseline in each graph. The value for 
the nonlavaged animal, parathryoidectomized for 18 hours, is given 
at the zero hour on the lavage time schedule. In the metaphysis, 
parathyroidectomy alone increased cytidine incorporation into RNA. 
There was no further effect due to lavage. This is the first time that 
we have been able, with our technique, to demonstrate a possible effect 
of endogenous parathyroid hormone on what I assume must be osteo- 
blast function. It appears that parathyroidectomy released a suppres- 
sor of RNA synthesis. Following stimulation by peritoneal lavage, 
the stimulation for RNA production in the mesenchyme-cell population 
reversed this suppression and 3H-cytidine uptake increased. This, 
of course, is speculation. 
The last point that I would like to emphasize is that there is a marked 
difference between the effects in the metaphysis and those in the di- 
aphysis. If we are correct 
in assuming, as we have indicated before, that the calcium homeostatic 
function is centered primarily in the areas of the diaphysis, we would 
interpret the data in this figure to indicate that the effects on RNA 
production here is not a mechanism by which certain bone cells are 
controlling calcium homeostasis, but rather a parathyroid stimulation 
is causing the cell to change its orientation, the forming of new osteo- 
clasts. 
Figure 47 illustrates 3H-thymidine uptake into DNA; it is merely 
to demonstrate that DNA is affected by the same system. Thymidine 
uptake is also affected, but there is a time delay. It suggests that 
the parathyroid stimulus increases the mitotic rate in the mesenchyme 
population, causing reorientation of a certain percentage of these cells 
into osteoclasts. 
To summarize, we believe that the stimulus of parathyroid hormone 
is not on the osteoclast itself, but on the mesenchyme cell population 
to produce more osteoclasts and that these latter cells are probably 
not concerned with the control of calcium homeostasis. 
Dr. Pritchard, I believe we have 
reached the point where it is clear-at least it is to me-that once a 
cell is differentiated as an osteoprogenitor cell, it can respond to hor- 
mones in various ways. Now can we discuss the subject of what 
This was mentioned briefly in Session 1. 
URIST: Thank you very much. 
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induces cells to differentiate into an osteoprogenitor cell; i.e., to get 
on Young’s wheel? 
PRITCHARD: I do not think we should take Young’s wheel for granted. 
We have a population in which some cells are dividing, some are 
differentiating, and others are differentiated and actively engaging in 
matrix formation or destruction. 
I would 
like to see some concrete evidence that osteoclasts actually break 
up into progenitor cells. 
There are many factors that can affect this cell system. I think 
Dr. Peck has information about a vitamin effect on the system and 
also Dr. Budy, about the effect of estrogen on bone. 
RAISZ: Dr. Peck and I have been discussing the issue of tissue 
culture versus studies on tissue in vivo. And since the question has 
been raised and not answered, I think in fairness to the various groups 
around the table who are using different systems in vivo and in vitro, 
we ought to attempt to clarify what these different approaches can 
achieve. In a conference on topics as complex as this, we could be- 
come further confused by going back and forth between in vivo and 
in vitro data. 
We are going to hear about what I regard as elegant in vitro data 
from Dr. Peck. This work proves something important about the 
way living cells work, but it does not prove anything about the way 
the precursors of these cells function in vivo. Dr. Fremont-Smith 
asked us to look at tissue culture to find answers to the questions 
that Dr. Young is raising. I would say that this was a wrong approach, 
because Dr. Young was asking an entirely descriptive question about 
the way in which a living system showed modulation of cells in response 
to external agents. I do not see how any in vitro system can tell you 
what the sequence of this cellular modulation would be. On the othe1 
hand, we can do much better experiments on the biochemistry of cell 
transformation in vitro. 
FREMONT-SMITH: he point I wished to make is that I believe tissue 
culture throws light on how cells function somewhere else. From this, 
one can make inferences that make it possible to understand better 
how cells function in their normal environment. 
RAISZ: Certainly, as long as you do not try to slide the data over 
into the in vitro situation. 
FREMONT-SMITH: There also has been a tendency to say nothing 
can be learned in vivo. I would like to make a prediction, and I would 
be willing to put it on the record. But 5 or 7 years from now, there 
will be new information from tissue culture which will have influenced 
our understanding of cells in vivo. 
There is still doubt as to the reversibility of this system. 
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BAUER: What is so special about tissue culture? Is it not true of 
all techniques, that one must simplify and that one must take into 
account a system which one is not studying? What is the difference 
between tissue culture and cytoanalysis? One has to introduce 
modification in all techniques. 
FREMONT-SMITH: These are all model systems, are they not? And 
none of our histology tells us what the living cell is, because all of the 
cells are dead. I think it is worth reminding those who are embedded 
in histology, which is an essential feature of our understanding, that 
they are not looking at living cells; they are making implications. 
The only place one can see living cells is in tissue culture, and these 
cells are not the same; they are in a different environment from those 
in vivo. It is this interaction balance, however, which I am sure will 
throw light on many fields. 
I think that the reaction one gets-I have seen it again and again in 
these conferences over 30 years - is a great reluctance to accept data 
coming from another technique or another field. Even the introduction 
of a new stain is very disturbing to histologists at times, until it becomes 
more standard. What I am working for, and one of the main purposes 
of our conference, is to see what we can each learn from the other’s 
techniques, not what we can throw out. 
TALMAGE: If one works with an isolated system such as tissue 
culture, the tendency is to explain the entire physiologic process on 
the basis of the results from the isolated system. In my opinion, one 
must make a sincere effort to study the entire physiologic process in 
the intact animal, and be very cautious of those results from isolated 
in vitro systems which appear contradictory or are unexplainable in 
relation to the physiologic process as seen in vivo. 
NICHOLS: Let us go on to Dr. Peck, Mr. Chairman. 
PRITCHARD: The problem is simply to find out how cells behave in 
different environments, both in vitro and in vivo. 
PECK: We have been working on a system that has certain similarities 
to Dr. Holtzer’s. We have been able to disperse cells from fetal and 
newborn rat calvaria using a crude collagenase preparation - inciden- 
tally, we cannot do it with trypsin-and have studied the cells from a 
number of standpoints; most recently, collagen synthesis (refs. 144 and 
145). We made no claims that the cells we have isolated are bone cells, 
for they have not been shown to produce bone in vitro, and it is quite 
likely that we have harvested a heterogeneous cell population. We 
have been primarily interested in the relationship between cell prolifera- 
tion, cell density, and responsiveness to humoral agents, in particular, 
ascorbic acid and parathyroid hormone. 
If we suspend cells in simple incubation medium, we can demonstrate 
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synthesis of a hydroxyproline-containing protein. The ability of these 
freshly isolated cells to form peptide-bound hydroxyproline is indicated 
in figure 72, which depicts the incorporation of radioactive proline into 
protein, and the appearance of radioactive hydroxyproline in protein, 
after incubation of cells with labeled proline. The appearance of 
hydroxyproline, which we can equate with collagen synthesis, increases 
during the first 6 hours of incubation. After 12 hours, no further 
hydroxyproline is formed. 
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FIGURE 72. Collagen synthesis of freshly isolated bone cells. Freshly isolated cells 
were incubated in Krebs’ Ringer bicarbonate buffer, pH 7.4, gas phase 95 percent 02. 
5 percent CO?. containing ~-proline-U-W, dialyzed bovine serum albumin 0.5 percent, 
glucose 0.1 1 M, and penicillin and streptomycin 100 units each per milliliter. Each point 
represents the mean of three flasks. [From ref. 145; reprinted by permission of the 
publisher.] 
FREMONT-SMITH: hese are all rat bone? 
PECK: These are from the calvaria of rat fetuses that have been 
dispersed by collagenase. Collagen synthesis by freshly isolated, 
suspended cells does not respond to a variety of humoral agents, 
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including insulin, parathyroid hormone, growth hormone and, most 
disturbingly, ascorbic acid. As you know, ascorbic acid has been 
found to stimulate collagen formation in a host of in vitro and in vivo 
studies with many types of connective tissues. Recause of this lack 
of responsiveness, we decided to maintain the cells under different 
circumstances. 
We dispersed the cells in cell culture on a flat surface, apparently 
in a fashion similar to the system used by Dr. Holtzer. The cells then 
go through a period of proliferation. Figure 73 indicates the amount 
of DNA in the culture with respect to days of culture. It may be 
seen to increase modestly. 
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FIGURE 73. Relationships between cell proliferation and appearance of proline and 
hydroxyproline radioactivity in protein during culture of bone cells on a flat surface. 
~-proline-U-'~C was added to each culture 12 hours before termination, hence data indi- 
cate radioactivity incorporated during the preceding 12 hours. [From ref. 145; re- 
printed by permission of the publisher.] 
If one 
begins with a lot of cells, they do not divide as many times as when 
one starts with fewer cells. This is because proliferation is limited by 
the area that contains the cells. Once the cells form a layer that fills 
the containing area, proliferation slows markedly. 
In this particular series we plated many cells to start with. 
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The important point in figure 73 is the appearance of collagen which 
is represented by the appearance of radioactive hydroxyproline in 
protein. This was determined by adding 14C-proline 6 hours before 
harvesting the culture, so that each point represents the collagen that 
has been synthesized during the preceding 6 hours. You can see that 
the rate of collagen synthesis increases with the duration of culture, 
increases with the accumulation of DNA, and increases with increasing 
density of the cell population. 
If you add ascorbic acid to this cell-culture system, you get a dramatic 
stimulation of the formation of hydroxyproline-containing protein 
(fig. 74). We call it collagen formation, at least in the biochemical 
sense. This is a dose-related phenomenon, as indicated by plotting 
on semilog paper the concentration of ascorbic acid in pglml against 
the appearance of hydroxyproline radioactivity expressed as pg of 
DNA in the culture. 
URIST: Is the collagenous material uncalcified? 
PECK: Yes. We have seen no evidence of bone formation in our 
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cultures. We have seen precipitation of amorphous material, the 
nature of which remains to be clarified. 
URIST: Have you transplanted the tissue back into a living animal? 
PECK: We have placed cells in Millipore chambers and implanted 
them intraperitoneally in growing rats. We get what appears to be, 
in the Millipore chambers, amorphous material. I discussed this 
material with Dr. Lent Johnson at the last Gordon Conference. 
URIST: Was it calcified? 
PECK: Yes. However, none of us could figure out what it was. 
To reiterate, there is a linear relationship between the log of the con- 
centration of ascorbic acid and the appearance of hydroxyproline 
(fig. 74). Note that the lower extremity of this curve represents a 
concentration of 0.5 pg/ml of ascorbic acid. Generally, the physiologic 
range of serum ascorbic acid concentrations in humans is about 25 to 
30 pg/ml. 
We were interested in the relationship of this ascorbic acid effect 
to the duration of treatment. As figure 75 indicates, we can detect 
changes with respect to stimulation of collagen formation within 30 
minutes of the addition of ascorbic acid. 
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FIGURE 75. Effect of duration of exposure to ascorbic acid on collagen synthesis by 
bone cells in primary culture; ~-proline-U-'~C was added to each flask 30 minutes before 
the end of the experiment. Collagen was isolated from the cell layers by two 15-minute 
extractions with 5 percent perchloric acid at 70" C. 
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PRITCHARD: I think one could make the point here that ascorbic 
acid acts on the cell and presumably acts through the DNA-RNA 
mechanism. 
PECK: Initially, it probably acts directly on the process of proline 
hydroxylation. I would like to think that the stability of the, collagen 
molecule is governed by the hydroxylation of some proline residues 
and that, in the absence of ascorbic acid, hydroxyproline-poor collagen 
accumulates. These changes can occur without postulating any funda- 
mental change in the mechanism of the protein synthesis. 
I wanted to go into this partly because of the preceding discussion 
about the value of in vitro systems. I n  vitro systems are uniquely 
suited to deriving strictly biochemical information in a highly controlled 
environment. This particular system may provide us with some 
information which will be of value with respect to what is going on 
in vivo, but to draw that conclusion at this point would be totally 
erroneous. 
I will say, in addition, that cultured cells will respond to parathyroid 
hormone in vitro with an inhibition of collagen synthesis which can 
be reversed by ascorbic acid. At present we are studying growth 
hormone to see if these cells will respond to that as well. 
PRITCHARD: You have a wonderful system which has already 
given much valuable information. 
NICHOLS: Dr. Peck has brought up several important things. One 
is to point out what happens to cells when they are removed from 
their site of origin. I wonder, Dr. Peck, if you could tell us%bout the 
comparative activity of cells when they are in their normal habitat 
on surfaces of calvaria, and when they are in suspension? 
Modification of all behavior by modification of physical surroundings 
is extremely important and may well be the control which lies behind 
differentiation. Incidentally, our in vitro systems are really useful 
here because with them we can examine directly how cells respond 
to such stimuli. 
PECK: One thing we might have done which would have been very 
helpful was to do essentially what Dr. Holtzer and his colleagues 
did when they incubated cartilage cells in a button (ref. 146). Our 
freshly isolated cells were incubated in suspension. We shook them 
fairly vigorously. It would be interesting to see if these cells main- 
tained more vigorous collagen formation if they were maintained in a 
button rather than suspended in a simple medium. 
The point which remains is obviously a critical one. These cells 
are derived from tissues that synthesize collagen at a fantastic rate; 
although we have not done too many studies relating the ability of 
cells to synthesize collagen with respect to the amount of DNA that 
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has been released from the bone, our data would at least suggest that 
the cells are markedly impaired in their ability to synthesize collagen 
by the process of isolation. This may be open to question, but I 
think the evidence is quite clear that these are altered cells or that at 
least some of the cells within the population we isolated are changed. 
PRITCHARD: There is another important topic we have not touched 
yet, the question of induction. I wonder if Dr. Saxen would like to 
say something about induction systems. 
SAXEN: I will briefly summarize the present situation in the field 
of embryonic induction and outline our way of thinking. In doing so, 
there will be no time to present the experimental evidence on which 
my summary is based, but I will say that most of it is derived from 
experiments with soft tissues. However, I hope that the general 
scheme I am going to formulate will be applicable to bone induction 
and osteogenesis as well, and that both Dr. Holtzer and Dr. Urist 
will comment on this aspect later. 
In my scheme (fig. 76), 1 have divided the differentiation of a hypo- 
thetical cell population into different steps. The responding tissue 
(which is shaded in the figure) receives an inductive stimulus from the 
inductor tissue at the beginning of the chain of differentiative events. 
1 do not intend to discuss the specificity of this stimulus, although I 
may say that I have certain doubts about its specific nature. Let us 
just call it a stimulus or trigger which initiates the differentiative proc- 
ess in our cell population. If the responding cells are to be capable 
UNDETERMINED LABILE DETERMINATION STABILE STAGE 
HETEROTYPIC HOMOTYPIC 
FIGURE 76. Differentiation of a hypothetical cell population. 
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of responding to this inductive stimulus (I), they should be competent 
(CJ - a characteristic known to disappear during subsequent develop- 
ment. 
As a result of this initial inductive stimulus, the responding cells 
become determined in a certain direction, and consequently lose 
their competence to respond to similar triggering stimuli. However, 
this stage of labile determination is followed by subsequent interactive 
processes. In some model systems at least, the primary stimulus is 
known to be followed by a second heterotypic induction (II), leading 
to subsequent determination of the cells. The cells at this stage now 
display another competence (CII), making them capable of responding 
to the second inductive stimulus. 
Subsequent to this (and perhaps even after several heterotypic 
actions), the responding cells become independent of such epigenetic 
stimuli, and develop autonomously. 
URIST: Please define the term “epigenetic.” 
SAXEN: It means “not genetically controlled.” 
URIST: Thank you. 
PRITCHARD: Perhaps I can sum up the discussion so far as follows. 
From the chemical standpoint, cell differentiation implies change in 
the kinds or amounts of a cell’s synthetic activities. Sooner or later 
these changes are reflected in the histologic picture- such as mitotic 
figures, changes of cell shape, size, structure, mobility, change in 
intercellular matrices, changes in the pattern and organization of the 
tissues composed of such cells and their matrices. 
It is postulated that these changes are brought about by a series of 
inducing stimuli which evoke responses from competent cells. 
The important questions are as follows: What is the nature of the 
inducing stimuli; where and how do such stimuli act on the cell; how 
do they select one response, or a particular set of responses, from 
the cell’s repertoire; what is competence in terms of DNA activity; 
how permanent are the changes induced; what happens when a cell 
loses one competence and gains another competence? 
Inducing stimuli are of many kinds, but-now we are particularly 
interested in the postulated close-range ones which act between one 
cell and another in its immediate range, which may be like it, or quite 
different. 
As I said, I do not know whether all of these are pertinent to bone 
induction or morphogenesis, and that is why I would very much like 
to have comments by Dr. Holtzer and Dr. Urist, who have been study- 
ing these problems. 
HOLTZER: 1 think I have spoken enough. I thought that was 
an excellent summary of the problem. 
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PRITCHARD: There are still one or two matters to be considered. 
Some of these concepts are called by different names in the literature; 
e.g., dependent differentiation, self-differentiation, autoinduction, 
heteroinduction. Also, there is the question of reversibility, whether 
one can dedetermine, dedifferentiate. 
HOLTZER: No; I disagree. I do not think we should wander all 
over using such words as they apply to different kinds of cells. I 
think we should ask Dr. Young or Dr. Peck questions, such as “When, 
in the life history of bone cells, do they first start making collagen?” 
or “Do they make collagen during mitosis, G-1, S, or G-2?” and so 
forth. 
YOUNG: I dq not believe it is made during S, when the cell is devoted 
to duplicating its DNA, and I do not think it is made during mitosis. 
I am sure it is made by osteoblasts during G-I. 
PRITCHARD: It must be made by progenitor cells in some stage 
of their life history. 
PECK: Now we are running into the problem we discussed previously 
of when to call collagen collagen. If one waits for morphologically 
identifiable collagen to be formed, the chances are that the dividing 
cell will no longer be able to make it. The question is, If there is an 
arrest in collagen synthesis, where does it occur? Is it arrested at 
an early stage of synthesis, for example, at the stage of proline hydroxy- 
lation, or is it a total arrest, presumably at the genetic level? 
YOUNG: My personal bias is that changes in cell specialization 
are mediated by the selective activation and repression of integrated 
groups of genes, but I do not think we should go into this now. I 
would like to hear what Dr. Urist has to say. 
OWEN: On the periosteal surface of the shaft of the femur of young 
rabbits, the osteoblasts line the surface of the bone and behind them 
are the preosteoblasts, their precursors. In this system, the uptake 
of glycine per cell in the precursors is about one-tenth the uptake in 
the osteoblasts. 
PRITCHARD: That is a very pertinent observation. 
NICHOLS: Dr. Howard Green has some evidence from tissue culture 
in another system which bears on this point of dividing cells (ref. 147). 
HOLTZER: Let us get together. A culture, in which some cells are 
dividing and some are not, is not a system which permits one to say 
whether or not a single dividing cell is making collagen. A cell in S 
is not doing the same thing that a cell in M is doing. 
PRITCHARD: This is an academic matter. 
HOLTZER: On the contrary, I think these are the only kinds of 
questions we can approach, otherwise we get back to defining cells 
by names. You wanted a definition of differentiation, what it means, 
and of reversibility, and so forth- 
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PRITCHARD: Call it the collagenoblast or mucopolysaccharidoblast, 
or something like that. 
HOLTZER: Names do not mean very much. We would like to know 
what a given cell does, and when and under what conditions it does 
it. We know that during M very little protein and very little RNA is 
made. What is the nature of such controls? What reactivates tran- 
scription and translation after each mitosis? One of the most central 
problems in all biology is what happens to the cell’s synthetic machinery 
so that it appears to shut down every time the cell goes through mitosis 
only to be activated in the following G-1. More information on this 
issue might give us a better basis for words, differentiation, dediffer- 
entiation, induction, and so forth. 
PRITCHARD: Perhaps we can leave this topic for the moment and 
call on Dr. Urist to talk about bone induction. 
URIST: The question is, What induces a cell to differentiate and 
to become an osteoblast? We do not know whether the tissue that 
Dr. Peck isolated, or the material that Dr. Holtzer explanted, con- 
tained induced cells. In the past we have assumed that a cell had been 
induced at an earlier stage of its development, if after transplantation 
it demonstrated its capacity to differentiate into an osteoblast. The 
conditions in tissue culture are less than adequate for osteogenesis, 
but in the anterior chamber of the eye, conditions are optimum. I 
will demonstrate osteogenesis induced by germinal cells of articular 
cartilage with the following figures to be discussed by Dr. SaxCn and 
Dr. Holtzer. 
When the cell is at the stage of development of an osteoprogenitor 
cell, it may be the differentiated form. We cannot tell the difference 
between a cell that is an osteoprogenitor and one that is a fibroprogenitor 
by morphologic criteria. We can get some idea by its location and by 
its rate of mitotic division. We would like to be able to identify an 
osteoprogenitor cell by its ultrastructure, but Dr. Robinson says that 
is not yet possible. We do know that because of its proximity to bone, 
it may have a strong tendency to differentiate into an osteoblast. 
The young cells in the germinal layer of the articular cartilage (epiph- 
yseal side) take up tritiated thymidine in larger amounts than other 
cartilage cells. When a thin slice of the surface of the articular car- 
tilage, a slice containing the flattened chondrocytes, is transplanted 
in the anterior chamber of the eye as an isograft or as an autograft, 
the product is either fibrous tissue or induction of new hyaline cartilage 
(fig. 77(a)). 
Another slice (fig. 77(b)), containing the deep or germinal layer of 
cells, induces bone formation. Before transplantation to the eye, the 
cartilage cells of the germinal layer were labeled with 3H-thymidine, 
and the cartilage matrix was labeled with 3H-glycine by intra-articular 
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FIGURE 77. Photomicrographs of sections of articular cartilage transferred to the 
anterior chamber of the eye. 
Tramplant is en- 
veloped in capsule of fibrous connective tissue; neither excavation chamber nor esteo- 
genesis is produced. 30X. 
(b) Coronal section, full thickness slice of cartilage: labeled chondrocytes (black and 
white arrow); excavation chamber filled with capillary sprouts, new connective tissue, 
and a pair of labeled chondrocytes liberated from their capsules and free in center (open 
arrow); excavation chamber filled with new cells but no labeled chondrocytes (solid 
arrow). 30X. 
(c) Autoradiograph: cement line dividing glycine-labeled old cartilage from layer of 
unlabeled new bone matrix (solid arrow); labeled chondrocytes (open arrow); labeled 
progenitor cells (P) and osteoblasts (0) suggest that labeled chondrocytes modulate into 
bone cells. 30X. 
(d) Ossicle formed from transplant. New lamellar bone (B) surrounds pool of marrow 
(M) and contains islands of unresorbed cartilage (C). 60X. 
(e) Complete replacement of donor tissue. Ossicle composed of compact cortical 
bone (B) and healthy hematopoietic marrow (arrow). 60X. 
PAS-hematoxylin stain. 
( a )  Thin slice of gliding surface of cartilage, 6 weeks in the eye. 
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injections. The labeled cartilage was transferred to the anterior 
chamber of the eye of another rat of the same inbred strain for a period 
of 3 weeks. There was no translocation of tritiated glycine from the 
matrix of the donor to the cytoplasm of the new cells of the host. 
Figure 77(c) is an autoradiograph of an area of osteogenesis in an 
excavation chamber in an isograft of articular cartilage. 
By means of tritiated thymidine labeling experiments, one can see 
that the cells dissolve the capsule and surrounding matrix and undergo 
mitotic division. The first mitotic division produces connective tissue 
cells that look like mesenchymal cells. Six weeks after the operation 
an ossicle is formed (fig. 7 7 ( 4 )  and there is complete replacement of 
all of the donor tissue (fig. 77(e)). 
The second, third, or fourth mitotic division- we do not 'know how 
many in 15 days- occurs in such a way that the capillary growing into 
the transplant interacts with the progeny of these germinal cells that 
have dedifferentiated or modulated, depending upon how one wants 
to look at it, and the interaction, or what Paul Weiss calls the swarming 
of these cells in two different locations, results in what appears to be a 
progenitor cell. We say this is a progenitor cell because its rate of 
uptake of tritiated thymidine is greater than that of any other cell in 
the area. It is by this criterion and by none other that we call it a 
progenitor cell. I am not even saying what kind, whether it is osteo- 
blast, chondroblast, hematoblast, or something else. 
PRITCHARD: You could call it a thymidine cell. 
URIST: You could call it a thymidine-labeled connective tissue cell. 
The progenitor cells differentiate into osteoblasts. The interaction 
of the progeny of the cells from two sources produced bone. The 
progeny of one population of cells induced the progeny of the other 
to become osteoblasts and to make bone. The cells were not induced 
to make more cartilage in the new environment in which their progeny 
proliferated; instead, the product was new bone. 
Figure 78 is a diagrammatic representation of the ordered sequence 
of events in the induction system for bone from articular cartilage. 
During the first 10 days after transplantation, the germinal cells of 
articular cartilage lyse the intercellular substance and divide mitotically 
to produce - . - - inducing .- - cells. Swarming occurs between - . -.- __ 10 and - 15 days, 
and a large number of ingrowing perivascuh inducible connective 
tissue cells of the host interact with a relatively small number of progeny 
of donor cells. Between 15 and 20 days, the donor tissue develops 
excavation chambers filled with sprouting capillaries and proliferating 
young connective tissue cells. Microscopically, the progeny of the 
donor and the host are identical, but functionally they are different 
insofar as some have been induced to differentiate or specialize as 
osteoblasts, chondroblasts, hematocytoblasts, or fibroblasts. Some 
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FIGURE 78. 
ular cartilage. 
Ordered sequence of events in the induction system for bone from artic- 
divide and produce more responding or undifferentiated connective 
tissue cells. Between 20 and 25 days, the induced cells differentiate 
into osteoblasts; between 25 and 30 days, the new bone containing 
osteocytes is deposited in one location while new marrow, fibrous 
tissue, and cartilage are deposited in another. Osteoclasts appeared 
only in association with bone tissue and with the onset of remodeling 
of the initial deposits. 
The questions, Dr. Saxen, are these: What was transferred from one 
cell population to another? Was anything transferred? Was the 
inducer something that arose intercellularly as a result of this change 
in environment, or was some chemical inducer transferred from the 
donor to host progeny? Can you explain this reaction with the aid 
of your hypothesis? 
SAXEN: I am afraid, Dr. Urist, I cannot answer your questions. 
I pointed out that we do know that there are what I call epigenetic 
factors, but we do not know anything, or very little, about their chemical 
nature and their mode of action. For instance, you mentioned the an- 
terior chamber of the eye. Kidney induction, as I showed, takes 
place under the very same conditions without its specific inducer. So 
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now there are people who are inclined to speak of “conditions” rather 
than of specific inducers. 
So the only thing I can say is that these cells have been exposed to 
different environments. Whatever it is in these environments that 
causes this determination is not known. 
I would like to know what Dr. Holtzer has to say about this; he is 
more familiar with these cells. 
URIST: Dr. Holtzer, in the embryonic notochordal tissue-spinal cord 
induction system for cartilage, is there evidence that a substance is 
transferred from one cell to another? 
HOLTZER: We have no evidence. 
URIST: Is there evidence of a diffusible substance? 
HOLTZER: Absolutely none. 
URIST: In the experiments of Lash et al. (ref. 148), did cartilage 
induction occur from a substance that diffused across a Millipore 
membrane? 
HOLTZER: There is an interaction. We never pretended that we 
had a molecule that we could name. We are asking a kind of question 
that is experimentally beyond our capacity, certainly my capacity right 
now, to analyze. That is why I prefer to refocus some of our questions 
in differentiation. We are all looking for little devils to send a cell 
in this direction, send a cell in that direction, and that’s the end of it. 
On the contrary, there is excellent evidence in the case of bone that 
it is not that simple; that there are no demons that open trapdoors and 
let a message come through and that is the end of the interaction. 
Therefore, why belabor something which people studying bone have 
demonstrated year after year? That is to say that there is continual 
interaction and that there are, in fact,.alterations in the states of a cell. 
We define, by specifying the activity, what we mean by states of 
alteration. 
The question you are asking, as far as I am concerned right now, is 
a rhetorical one because nobody has any evidence that an information- 
bearing molecule comes from one source, goes into another cell, and 
diverts that cell to another task. 
PRITCHARD: In some setups, surely it does; you are a male and I 
am a male because at a certain stage in our development a certain 
hormone was produced by- 
HOLTZER: Remember, I said “an information-bearing molecule” 
which changes the fate of a cell. By and large, hormones and other 
exogenous molecules accelerate or dampen an activity; they permit 
cells to express a capacity that was built into them by their previous 
history. To my knowledge there is no conclusive evidence that the 
known hormones establish that capacity. A hormone acts on a target 
cell. But the inductive influence, which initially guided the differentia- 
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tion of that target cell, was not that particular hormone. Hormones 
act on programed cells, not naive cells. Hormones select preset 
programs. The central problem of differentiation is the nature of the 
influences that establish the programs. At this point, with the possible 
exception of vitamin A, there is no clear-cut evidence of an “informa- 
tion-rich” molecule from one cell entering another and thereby altering 
the latter’s fate. 
PRITCHARD: A hormone is an information-bearing molecule. 
HOLTZER: Does it go inside the second cell? 
PRITCHARD: Yes. 
HOLTZER: I am sorry; you might be right. 
PRITCHARD: You see, once you label these things- 
HOLTZER: I am sorry-I do not accept any of that work. 
SAXEN: I would like to add something to this matter of specific action. 
In quite another system, the developing central nervous system, it has 
been shown that factors such as CO, shock, a slight change in the pH 
of the environment, and things like that can trigger this chain of events. 
In these situations we certainly are not dealing with an information 
molecule, and that is one reason why 1 said I have my doubts about 
the specificity of this approach. 
RAISZ: Dr. Urist, have you tested any changes in the microenviron- 
ment in the eye for the ability to induce bone; for example, calcium 
changes or something of that sort? 
URIST: Some years ago in Dr. McLean’s laboratory, Heinen (ref. 
149) put rats on a phosphate-deficient diet, made them rachitic, cultured 
the bone, and transplanted the culture to the anterior chamber of the 
eye. The new bone was phosphate-deficient and vitamin D-deficient 
rachitic bone or osteoid tissue. The culture differentiated into bone, 
but the matrix did not calcify. Bone induction can take place even 
under conditions that are not conducive to calcification of the matrix. 
RAISZ: That is what I was asking you: whether there were times 
that one could get cartilage or bone under some conditions of changing 
environment. 
URIST: Yes; we will try to get to that question when we present a 
few more experimental observations. 
We implanted a segment of HC1-decalcified lyophilized cortical 
bone into a pouch in the anterior abdominal wall, or the quadriceps 
muscle, and observed bone induction in excavation chambers inside 
the old matrix. Cartilage induction occurred inside old vascular 
channels. 
FREMONT-SMITH: What was the origin of the decalcified bone? 
Also rabbit? 
URIST: Yes, rabbit; we employed bone from the same or another 
individual. 
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FREMONT-SMITH: Is the effect not species specific? 
URIST: No; it is not. We have also observed what Dr. Saxen calls 
heterogenous induction with implants of bovine and human matrix 
in rabbits (ref. 150), but the inflammatory reaction is high, the percent 
positive results low, and the yield of bone is very, very smaK 
I will now show some examples of bone induction by heterogenous, 
dead, decalcified bone matrix. Figure 79(a) is an implant of bovine 
decalcified bone matrix in the anterior abdominal wall of a rabbit. 
The implant is enclosed in an envelope of plasma cells, lymphocytes, 
reticulocytes, and foreign body giant cells. Figure 79(b) illustrates 
scanty deposits of new bone on the surfaces of an implant of dead, 
decalcified bovine matrix, inside the envelope of inflammatory tissue 
in the anterior abdominal wall of a rabbit, 12 weeks after the operation. 
Figure 79(c)  shows the implant of bovine dead, decalcified bone matrix 
in the anterior abdominal wall of a rat, 12 weeks after the operation. 
The rat has a high propensity for formation of cartilage on the walls 
of vascular channels in the old matrix. These cells differentiate from 
histiocytes that wander into and repopulate nearly every crevice and 
space with new cells. In the process of cartilage induction, there is 
little or no resorption of the inducing surface. 
It is necessary to emphasize, however, that while the inducing 
material is heterogenous in origin, in these systems both the inducing 
cells and the induced cells come from the host bed. For this reason, I 
refer to an article on bone formation by autoinduction (ref. 15 1). 
We have implanted decalcified, lyophilized muscles, tendon, kidney, 
and other tissues into the anterior abdominal wall, and the results 
were negative over a period of 8 weeks. It is necessary to extend 
this experiment to 3 to 6 months; bone formation does not appear in 
injured tendons until after 3 months. Cartilage, however, is different; 
decalcified, lyophilized costal cartilage will induce bone formation 
with an incidence of over 60 percent positive results. 
PRITCHARD: Dead cartilage and muscle will also show this, and 
there is a comparable delay before new bone appears. 
URIST: Bone induction was influenced by the effects of the acid 
that was used to decalcify the matrix. Nitrous and nitric acids, which 
deaminate protein, prevent bone induction; HCI, EDTA, and formic- 
citric acid do not alter the matrix in a comparable way and do not 
inhibit bone induction. Nitric acid-decalcified matrix produces an 
extensive foreign body giant cell response. 
Figure 80(a) illustrates a deposit of new bone on the walls of an 
excavation chamber in an implant of homogenous dead, decalcified 
bone matrix, 4 weeks after the operation in a rabbit. Figure SO@) 
shows deposit of new bone and remnants of an implant of old dead, 
homogenous, decalcified bone matrix in a rabbit 8 weeks after the 
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FIGURE 79. 
terior abdominal wall of the following: 
reticulocytes, and foreign-body giant cells (arrow). 
of inflammatory tissue. 
Photomicrographs of bovine decalcified bone matrix implants in the an- 
(a) Rubbif-the implant is enclosed in an envelope of plasma cells, lymphocytes, 
(b )  Rabbit-scanty deposits of new bone (arrow) on surface of implant inside envelope 
( e )  Raf-cartilage on walls of vascular channels in the old matrix (arrows). 
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FIGURE 80. Photomicrographs of homogenous, dead, decalcified bone matrix implants 
in the anterior abdominal wall of a rabbit. 
(u )  New bone deposit on walls of excavation chamber; osteocyte (solid arrow) and 
empty lacuna (open arrow) in substance of the old matrix. 
(b)  New bone deposit (open arrow); remnants of old dead bone matrix (solid arrow); 
bone marrow (M). 
(c) Decalcified, lyophilized bone matrix (D); chondrogenesis ( C )  in an old vascular 
channel; osteogenesis ( B )  in new excavation chamber. 
( d )  Decalcified, lyophilized costal cartilage; excavation chamber (E) filled with pro- 
liferating connective tissue in old acellular dead cartilage (C), deposit of new bone (B) 
and implant enclosed in a sheath of fibrous connective tissue (arrow). 
HEA stain. 
operation. Figure 80(c) is an implant of HCI-decalcified, lyophilized 
bone matrix showing chondrogenesis in an old vascular channel and 
osteogenesis in a new excavation chamber. Figure 80(d) is a section 
of lyophilized, decalcified, homogenous costal cartilage, 8 weeks 
after implantation in the anterior abdominal wall of a young rabbit. 
The excavation chamber is filled with proliferating connective tissue 
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FIGURE 8 I .  Photomicrographs of implants in the anterior abdominal wall. 
(a) Island of new cartilage (arrow) on inner wall of decalcified homogenous bone 
matrix (D); new bone (bottom) and old dead matrix (top) surround area of chondro- 
genesis. 
(6) Homogenous dead, decalcified, lyophilized nasal cartilage (N); induction of new 
cartilage formation (arrow). 
( c )  Homogenous dead. decalcified, lyophilized nasal cartilage (arrow); formation of 
excavation chamber and induction of new bone formation ( B ) .  
in old acellular dead cartilage, there is deposit of new bone, and the 
implant is enclosed in a sheath of fibrous connective tissue. 
Figure 81(a) shows an island of formation of new cartilage on the 
inner wall of an implant of decalcified, homogenous bone matrix 6 
weeks after the operation. Such masses of cartilage are later resorbed 
and replaced by new bone through typical endochondral ossification. 
New bone and old dead matrix surround the area of chondrogenesis. 
Figure 8 l(6) is an implant of homogenous, dead, decalcified, lyophilized 
nasal cartilage of a rat implanted in the anterior abdominal wall of a 
rat showing induction of new cartilage formation. Figure 81(c) is 
an implant of homogenous, dead, decalcified, lyophilized nasal cartilage 
showing formation of an excavation chamber and induction of new bone 
formation 6 weeks after the implant operation. 
BELANGER: Were all of these made at the same time approximately? 
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URIST: The implants were excised at intervals of 4, 6 ,  8, and 12 
weeks after the operation. 
HOLTZER: Cells are invading the matrix. Can you say anything 
about them? 
URIST: Yes; leukocytes, histiocytes, foreign body giant cells, 
sprouting capillaries, and perivascular connective tissue cells pass 
in review through the tissue in sequence at various times in various 
proportions, in various sites in the implant. The implant is at first 
unoccupied territory that gradually becomes repopulated with cells. 
Figure 82(a) is homogenous, decalcified bone from a Belgian rabbit 
implanted in the anterior abdominal wall of a New Zealand rabbit 
without lyophilization, 4 weeks after the operation. Note the infiltra- 
tion of inflammatory connective tissue cells and the dissolution of the 
bone matrix, but no new bone formation. Bone induction is retarded 
or suppressed by inflammation either from an immune response or 
from sepsis. Figure 82(6) is a roentgenograph of the anterior abdom- 
inal wall of a rabbit containing eight Millipore chambers. Four 
chambers contain transplants of fresh, autogenous, cancellous, viable 
bone tissue, and four contain 0.6 N HC1-decalcified dead bone matrix, 
4 weeks after the operation. Bone tissue was formed inside, never 
outside, the membrane of the Millipore chamber containing viable 
bone tissue. There was no bone formation either inside or outside 
the chambers containing dead, decalcified bone matrix. When there 
was a defect in the Millipore membrane, the host cells were found 
in a stream growing into the chamber; these cells were able to gain 
contact with the dead matrix to set up an induction system for 
osteogenesis. 
SAXEN: The grafts are not rejected when you use a heterograft? 
URIST: The plasma cell-reticulocyte reaction around the implant 
suggests that it is rejected. Instead, 
it is encapsulated in an envelope of inflammatory connective tissue 
cells. It is understandable that prolonged inflammation would inhibit 
cellular differentiation of cartilage and bone. Prolonged inflammation 
should induce differentiation of leukocytes and macrophages; cells 
specializing in phagocytosis, not in production of intercellular 
substances. 
Except that cell specialization may begin in the aftermath of sterile 
inflammation at about 21 days, it is difficult to understand’how chon- 
drogenesis is induced in the blind end of an old vascular channel, or 
how osteogenesis is induced on the walls of an excavation chamber 
in decalcified matrix. In the case of cartilage, the surface of old matrix 
appears to be unaltered morphologically. On a molecular level, of 
course, it is possible to envisage a mechanism whereby the old matrix 
I 
But it cannot be discarded. 
31 1-496 0-68-14 
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FIGURE 82. Implants in anterior abdominal wall of rabbit. 
(a)  Photomicrograph of inflammatory response from heterograft. 
(b) Roentgenograph of abdominal wall with Millipore chambers in situ; fresh autoge- 
nous, cancellous, viable bone (open arrow); decalcified, dead bone matrix (solid arrow). 
may transfer a template of protein structure onto the plasma membrane 
of young connective tissue cells; this can be transferred to the ribosomal 
membranes and then relayed to the regulator genes to produce cellular 
differentiation, either of a chondroblast or an osteoblast. These 
ideas, however, are conjectural and do not take into consideration many 
other factors in the host bed that are unspecific or unknown in nature. 
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PRITCHARD: I would like to show a figure of an implant of dead 
muscle that is being invaded by cells which turn into cartilage cells 
in an almost identical manner (fig. 83). 
CURREY: Was this piece of muscle frozen? 
PRITCHARD: No;  it was fixed in acetone, but we are evidently 
URIST: The phenomenon is similar but not the same. 
SAXEN: Dr. Urist, do you have any information on the distance; 
that is, how far from the graft will new bone be formed? 
URIST: The first row of cells in contact with the old decalcified 
matrix may differentiate into a row of osteoblasts, but we have seen 
the second row of cells produce bone without direct contact with the 
implant. 
If there 
is a transmission of something, there should be a maximal distance, 
which is quite well known in different induction systems. 
URIST: The cells that grow in with a capillary sprout and produce 
an excavation chamber are the same cells that become osteoprogenitor 
cells, osteoblasts, and new bone. The distance across the excavation 
chambers produced by these cells is approximately 100 to 150 microns 
dealing with a similar phenomenon. 
SAXEN: How far from the graft is this new activity seen? 
FIGURE 83. 
fixed tongue muscle of the rabbit implanted beneath the kidney capsule. 
Photomicrograph showing rows of cartilage cells between fibers of acetone- 
500X. 
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in diameter. Does a chemical substance diffuse from matrix into the 
cytoplasm of the matrix-resorbing cells? Perhaps later I will present 
some experiments designed to potentiate, to degrade, or to inactivate 
the matrix that produced a bone induction system. 
It should be noted that extraction or partial denaturation of the 
decalcified matrix with alcohol, strong salt solution, ether, acetone, 
and detergents did not retard bone induction. Autogenous bone matrix 
was not better than homogenous bone matrix for bone induction when 
implanted after devitalization, decalcification, denaturation, and 
extraction by these agents. Heating the implant to 100" C gelatinized 
the matrix and, like nitric acid and FDNB, prevented bone induction. 
Thus, although the structure of the protein of the bone matrix is an 
important factor, it is impossible to assume that something diffusible 
was transferred to ingrowing cells. 
PRITCHARD: One can approach the problem in part by morphology. 
Whatever material is excavated, there is always a chance that the 
mesenchyme that goes in will make bone. It is a common phenomenon. 
The tunneling is done in the hard material; then the cells differentiate 
on the walls of the tunnels. Because these cells, sitting on the walls 
of the tunnel, are in direct contact with the bone, the distance is virtually 
nil. That was the question Dr. Saxen was asking. 
URIST: The line of contact between the decalcified material and the 
cell might consist of one cell or one layer of cells; but the influence of 
the substance of the old bone matrix is upon a new population of cells, 
many of which do not appear to have direct contact with the implanted 
material. It is possible that a relay system is involved; the first layer 
of responding cells may become a layer of inducing cells, and layer by 
layer the inducer is transmitted from one cell to the next until the 
excavation chamber is filled with a laminated mass of bone except for a 
single blood vessel in the center. 
PRITCHARD: Which one turned into the osteoblast, the one on the 
surface or the one in the middle? 
URIST: Sometimes we see osteoblasts developing in an area separated 
from the old matrix by several layers of cells. 
PRITCHARD: I have not seen this. 
URIST: We do not see osteogenesis only in lines of contact with the 
old decalcified matrix; two or three layers of cells may be involved 
in the process in some areas of the resorbing implant. 
I will try to present some experiments on matrix treated with blocking 
reagents and enzymes, designed to show whether or not something 
is transferred. 
The question that we have before us is, What is the arrangement of 
the young connective tissue cells when a bone-induction system 
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begins in the interior of an implant of HC1-decalcified, lyophilized bone 
matrix, 2 1 days after the operation? Figure 84(a) is a section showing 
the old matrix, or inducing surface; the layer of young connective tissue 
cells, a mixture of inducing cells and reponding cells, in contact with 
the inducing surface; layers of proliferating fibrous connectix tissue 
cells, or pool of new responding cells; and the mass of loose fibrous 
connective tissue and inflammatory cells. 
Figure 84(b) is a higher magnification of the mixture of inducing 
and responding cells; the area indicated by (B) is the first layer in 
contact with the inducing surface, or old matrix. There is densely 
staining basophilic cytoplasm of some of the cells, resembling osteo- 
blasts. Others with clear cytoplasm and dense nuclei resemble 
osteoprogenitor cells. Figure 84(c) shows connective tissue in the 
center of the implant of decalcified matrix in a rabbit given an arterial 
injection of india ink to label the macrophages. Deposits of new 
cartilage are seen in the old vascular channels. A higher magnification 
FIGURE 84. Photomicrographs of sections of HC1-decalcified, lyophilized bone matrix 
implants 2 1 days after the operation. 
(a) Old matrix (A) ,  layer of young connective tissue cells (B), layers of proliferating 
fibrous connective tissue cells (C), and loose fibrous connective tissue and inflammatory 
cells (D). 
(b)  Old matrix (A);  first layer in contact with inducing surface (B) .  
(c) Center of decalcified matrix (solid arrow) after injection of india ink to label macro- 
phages (open arrow). Note deposits of new cartilage ( C )  in old vascular channels. 
(4 Location of macrophages filled with phagocytosed particles of india ink; none was 
found in macrophages in contact with old decalcified matrix. 
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of this area is shown in figure 84(d) to demonstrate the location of 
macrophages filled with phagocytosed particles of india ink; none was 
found in macrophages in contact with the old decalcified bone matrix. 
In summary, the observations on early stages of bone induction 
suggest that the young connective tissue cells in contact with the bone 
matrix are several layers in thickness. During the period from 19 to 
23 days after the +operation, the young proliferating cells may move on 
and off the inducing surface, interact and swarm. At approximately 
24 days a layer of osteoblasts appears, and bone is formed on the in- 
ducing surface of old matrix. After that, the layer of new bone may 
become the inducing surface, and the next layer of osteoblast may 
become the inducing cells, and so on. 
To determine the sequence of events and the mitotic activity of the 
layer of inducing cells in contact with bone matrix, the host was injected 
with 3H-thymidine and the implant excised at 1 and 5 days later during 
the 19- to 23-day period of bone induction. Autoradiographs demon- 
strated that the cells with the highest percentage of labeled nuclei 
were located along the inducing surface of old matrix and near areas 
of osteogenesis. The cells with the lowest percentage of labeled 
nuclei were located in areas of resorption and phagocytosis and some 
distance away from areas of osteogenesis. The percentage of labeled 
cells was also low in areas of chondrogenesis, possibly because the rate 
of mitosis of the cartilage cells is relatively low compared with that of 
osteoprogenitor cells. 
